texas oncology more breakthroughs. more victories
  • Request an Appointment
  • Find a cancer center
  • Find a provider
  • Clinical Trials

Share:

 
 

Physician Publications

Date
Physicians
Publication
Title
Berenson J, Manges R, Badarinath S, Cartmell A, McIntyre K, Lyons R, Harb W, Mohamed H, Nourbakhsh A, Rifkin R.
American Journal of Hematology 
A phase 2 safety study of accelerated elotuzumab infusion, over less than 1 hour, in combination with lenalidomide and dexamethasone, in patients with multiple myeloma
Cooke KJ, Patt DA, Prabhu RS.
American Society of Clinical Oncology Educational Book
The Road of Mentorship
Patt DA, Bernstam EV, Mandel JC, Kreda DA, Warner JL.
American Society of Clinical Oncology Educational Book
More Medicine, Fewer Clicks: How Informatics Can Actually Help Your Practice.
Buys SS, Sandbach JF, Gammon A, Patel G, Kidd J, Brown KL, Sharma L, Saam J, Lancaster J, Daly MB
Cancer
A Study of Over 35,000 Women with Breast Cancer Tested with a 25-Gene Panel of Hereditary Cancer Genes
Dickler MN, Tolaney SM, Rugo HS, Cortés J, Diéras V, Patt D, Wildiers H, Hudis CA, O'Shaughnessy J, Zamora E, Yardley DA, Frenzel M, Koustenis A, Baselga J.
Clinical Cancer Research
MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2- Metastatic Breast Cancer
Loeb S, Ross AE
Current Opinions in Urology
Genomic testing for localized prostate cancer: where do we go from here?
Robert NJ, Goertz HP, Chopra P, Jiao X, Yoo B, Patt D, Antao V.
Drugs Real World Outcomes
HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes
Nguyen PL, Haddad Z, Ross AE, Martin NE, Deheshi S, Lam LLC, Chelliserry J, Tosoian JJ, Lotan TL, Spratt DE, Stoyanova RS, Punnen S, Ong K, Buerki C, Aranes M, Kolisnik T, Margrave J, Yousefi K, Choeurng V, Davicioni E, Trock BJ, Kane CJ, Pollack A, Davis JW, Feng FY, Klein EA
European Urology
Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens
Bersabe AR, Aden JK, Shumway NM, Osswald MB
Journal of Clinical and Diagnostic Research
Peripheral Smear Review and Bone Marrow Biopsy Correlation

Download full publication here.

Mayer RR, Frankfort BJ, Strickland BA, Debnam JM, McCutcheon IE, Groves MD, Weinberg JS
Journal of Clinical Neuroscience
Leptomeningeal metastases presenting exclusively with ocular disturbance in 34 patients: A tertiary care cancer hospital experience
Debnam JM, Mayer RR, Chi TL, Ketonen L, Weinberg JS, Wei W, Groves MD, Guha-Thakurta N
Journal of Clinical Neuroscience
Most common sites on MRI of intracranial neoplastic leptomeningeal disease
Dalela D, Santiago-Jiménez M, Yousefi K, Karnes RJ, Ross AE, Den RB, Freedland SJ, Schaeffer EM, Dicker AP, Menon M, Briganti A, Davicioni E, Abdollah F
Journal of Clinical Oncology
Genomic Classifier Augments the Role of Pathological Features in Identifying Optimal Candidates for Adjuvant Radiation Therapy in Patients With Prostate Cancer: Development and Internal Validation of a Multivariable Prognostic Model
Cines DB, Wasser J, Rodeghiero F, Chong BH, Steurer M, Provan D, Lyons R, Garcia-Chavez J, Carpenter N, Wang X, Eisen M.
Haematologica
Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia.
David Jacob Andorsky, Abdulraheem Yacoub, Jason M. Melear, Morton Coleman, Kathryn S. Kolibaba, Heather Dawn Brooks, ...Jacob D. Bitran, Suzanne R. Fanning, Frederick Lansigan, Justin L. Ricker, Kenneth A. Foon, Dongfang Liu, Mary Llorente, Jiahui Li, Jeff Porter Sharman
Journal of Clinical Oncology
Phase IIIB randomized study of lenalidomide and rituximab followed by maintenance in relapsed/refractory non Hodgkins lymphoma in patients with double refractory or early relapsed follicular lymphoma
Bassel F. El-Rayes, Donald A. Richards, Allen Lee Cohn, Stephen Lane Richey, Trevor Feinstein, Madappa N. Kundranda, ...Anthony B. El-Khoueiry, Jason M. Melear, Fadi S. Braiteh, Matthew Hitron, Waldo Feliu Ortuzar, Waheed Khan, Bo Xu, Wei Li, Youzhi Li, C J Li
Journal of Clinical Oncology
BBI608-503-103HCC: A phase Ib/II clinical study of napabucasin (BBI608) in combination with sorafenib or amcasertib (BBI503) in combination with sorafenib (Sor) in adult patients with hepatocellular carcinoma (HCC)
Buckley, A, Chapman E, Dinkelspiel HE, Caputo T, Holcomb K
Journal of Minimally Invasive Gynecology
Feasibility and Learning Curve of Robotic Laparo-Endoscopic Single Site Surgery in Gynecology
Druskin SC, Ward R, Purysko AS, Young A, Tosoian JJ, Ghabili K, Andreas D, Klein E, Ross AE, Macura KJ
Journal of Urology
Dynamic Contrast Enhanced MRI Improves Classification of Prostate Lesions: A Study of Pathologic Outcomes on Targeted Prostate Biopsy
Gorin MA, Rowe SP, Patel HD, Vidal I, Mana-Ay M, Javadi MS, Solnes LB, Ross AE, Schaeffer EM, Bivalacqua TJ, Partin AW, Pienta KJ, Szabo Z, De Marzo AM, Pomper MG, Allaf ME
Journal of Urology
PSMA-targeted 18F-DCFPyL PET/CT in the Preoperative Staging of Men with High-risk Prostate Cancer: Results of a Prospective Phase II Single-Center Study
Roger M. Lyons, M.D., FACP
Leukemia Research
Relation Between Chelation and Clinical Outcomes in Lower-Risk Patients with Myelodysplastic Syndromes
King, H.
Medical Advisor for US Oncology National Meeting, Houston, TX
Incorporation of Breast Surgeons – Discussion of Bringing Breast Surgeons Into an Established Medical Oncology Practice
King, H.
Medical faculty for Faxitron International Distributors Conference. Amsterdam, The Netherlands
Evolution of the Sentinel Lymph Node Biopsy.
Chamberlain M, Junck L, Brandsma D, Soffietti R, Ruda R, Raizer J, Boogerd W, Taillibert S, Groves MD, Le Rhun E, Walker J, van den Bent M, Wen PY, Jaeckle KA
Neuro-Oncology
Leptomeningeal Metastases: A RANO Proposal for Response Criteria
Tosoian JJ, Druskin SC, Andreas D, Mullane P, Chappidi M, Joo S, Ghabili K, Agostino J, Macura KJ, Carter HB, Schaeffer EM, Partin AW, Sokoll LJ, Ross AE
Prostate Cancer Prostatic Diseases
Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice
Eaton L, Kueck A, Maksut J, Gordon L, Metersky K, Brewer M, Siembida E,
Bradley A.
Sexual Medicine
Sexual Health, Mental Health and Beliefs About Cancer Treaments Among Women Attending a Gynecologic Oncology Clinic
Society for Neuro-Oncology
Leptomeningeal Metastases in 2017; Outcomes with Aggressive Multimodaily Management
American College of Gastroenterology
Upper Alveolar Ridge Metastases from Colon Cancer: A Unique Presentation of Metastatic Colon Cancer
Sprunt, JM, Silverstein MJ.
American Society of Breast Surgeons
Age Under 40 Is a Predictor of Poor Breast Cancer Outcome.
Sprunt, JM, J Lang.
American Society of Breast Surgeons
Incidence Rate and Outcomes for Palpable Ductal Carcinoma In Situ in the Contemporary Era.
David J. Andorsky, MD, Abdulraheem Yacoub, MD, Jacob D. Bitran, MD, Jason Melear, MD, Heather D. Brooks, MD, BS, BA, Kenneth A. Foon, MD, Syed Rizvi, MD, Mary Llorente, Jiahui Li, PhD and Jeff P. Sharman, MD
American Society of Hematology
MAGNIFY: Phase IIIB randomized study of lenalidomide and rituximab followed by lenalidomide versus rituximab maintenance in subjects with relapsed/refractory follicular, marginal zone, and mantle cell lymphoma.
Mittendorf E.A., Ardavanis A., Symanowski J., Murray J.L., Shumway N.M., Litton J.K., Hale D.F., Perez S.A., Anastasopoulou E.A., Pistamaltzian N.F., Ponniah S., Baxevanis C.N., von Hofe E., Papamichail M., Peoples G.E.
Annals of Oncology
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence.
Jackson, D and Perez, S and Hale, D and Greene, J and Schneble, E and Martin, J and Flores, M and Berry, J and Trappey, A and Vreeland, TJ, Hardin MO, Clifton GT, Herbert GS, Shumway, N, Papamichail M, Mittendorf EA, Peoples GE
Annals of Surgical Oncology
Correlation Between Preexisting Immunity and Clinical Response in a Phase II Trial Using HER2-Based Peptide Vaccines to Prevent Breast Cancer Recurrence
Vreeland TJ, Jackson DO, Hale DF, Greene JM, Schneble EJ, Martin J, Flores M, Berry JS, Trappey AF, Hardin MO, Clifton GT, Herbert GS, Perez S, Shumway N, Papamichail M, Peoples GE, Mittendorf EA.
Annals of Surgical Oncology
Efficacy of Booster Inoculations in a Phase II Trial of GP2, a HER2-Derived Peptide Vaccine, for the Prevention of Breast Cancer Recurrence
Hardin MO, Jackson DO, Hale DF, Greene JM, Schneble EJ, Martin J, Flores M, Berry JS, Trappey AF, Vreeland TJ, Clifton GT, Herbert GS, von Hofe E, Perez S, Shumway N, Papamichail M, Peoples GE, Mittendorf EA. 
Annals of Surgical Oncology
Impact of Boosting in the Phase II Trial of the AE37+ GM-CSF Vaccine in High-risk Breast Cancer Patients to Prevent Recurrence
Trevor J. Bledsoe, Anisha R. Noble, Chandana A. Reddy, Brian B. Burkey, John F. Greskovich, Tobenna Nwizu, David J Adelstein, Jerrold P. Saxton, and Shlomo A. Koyfman
Anticancer Research
Split-Course Accelerated Hypofractionated Radiotherapy (SCAHRT): A Safe and Effective Option for Head and Neck Cancer in the Elderly or Infirm
Tan L, Wang W, He G, Kuick RD, Gessner G, Kueck AS, Wahl H, Opipari AW, Liu JR
Cancer
Resveratrol Inhibits Ovarian Tumor Growth in an in Vivo Mouse Model
Dinkelspiel HE, Matrai C, Pauk S, Pierre-Louis A, Chiu YL, Gupta D, Caputo TA, Ellenson LH, Holcomb KM
Cancer Invest
Does the presence of endometriosis affect prognosis in ovarian cancer?
Giuliani M, Hope A, Mangona VS, Guckenberger M, Mantel F, Peulen H, Sonke J, Belderbos J, Werner-Wasik M, Ye H, Grills IS.
Clinical Lung Cancer
Predictors and Patterns of Regional Recurrence Following Lung SBRT: A Report From the Elekta Lung Research Group.
Johnson MD, Sura K, Mangona VS, Glick A, Ye H, Grills IS
Clinical Lung Cancer
Matched Pair Analysis of High Dose versus Standard Dose Definitive Chemoradiation for Locally Advanced Non-small Cell Lung Cancer.
Herman MP, Amdur RJ, Werning JW, Dzeigelwski P, Kirwan J, Morris CG, Mendenhall WM.
European Archives of Oto-Rhino-Laryngology
Elective Neck Management for Squamous Cell Carcinoma Metastatic to Parotid-area Lymph Nodes
Kennedy WR, Herman MP, Deraniyagala RL, Amdur RJ, Werning JW, Morris CG, Mendenhall WM.
European Archives of Oto-Rhino-Laryngology
Radiotherapy alone or combined with chemotherapy as definitive treatment for squamous cell carcinoma of the tonsil
Wilks, Sharon T. & Schnadig, Ian
Future Oncology
APF530 (Granisetron Inj Extended-Release) in a Three-Drug Regimen for Delayed CINV in Highly Emetogenic Chemotherapy
Hancock KL, Clinton CM, Dinkelspiel HE, Saab J, Schneider B, Caputo TA
Gynecologic Oncology Reports
A case of mesothelioma masquerading pre-operatively as ovarian cancer and brief review of the literature
Priyanka Bhateja, Matthew C. Ward, Grant H. Hunter, John F. Greskovich, Chandana A. Reddy, Tobenna I. Nwizu, Eric Lamarre, Brian B. Burkey, David J. Adelstein and Shlomo A. Koyfman
Head and Neck
Impaired vocal cord mobility in T2N0 glottic carcinoma: Suboptimal local control with Radiation alone
Agiro A, Ma Q, Acheson AK, Wu SJ, Patt DA, Baron JJ, Malin J, Schilsky RL, Lyman GH
Journal of Clinical Oncology
Risk of Neutropenia-Related Hospitalization in Patients Who Received Colony-Stimulating Factors with Chemotherapy for Breast Cancer
Patel K, Shaikh F, Ren B, Singhi Aatur, Ma C, Sun W.
Journal of Clinical Oncology
Expression of programmed death-ligand 1 (PD-L1), mismatch repair status, and Epstein-Barr status in locally advanced gastric adenocarcinoma: Correlation to clinical outcome.
Ma C, Patel K, Shaikh F, Ren B, Sun W.
Journal of Clinical Oncology
Frequent programmed death-ligand 1 expression in gastric cancer associated with Epstein-Barr virus or microsatellite instability: Implications for predictive biomarker development.
Journal of Clinical Oncology
Comparison of Survival Outcomes and Demographic Trends of Uterine Sarcomas Between a Single Institution and the National Surveillance Epidemiology & End Result Database (SEER) from 2002-2012
Hirsch BR, Burke JM, Agrawal M, Hauke RJ, Hutson TE, Doshi G, et al.
Journal of Kidney Cancer and VHL
Sequential therapy in metastatic renal cell carcinoma.
Raizer JJ, Giglio P, Hu J, Groves M, Merrell R, Conrad C, Phuphanich S, Puduvalli VK, Loghin M, Paleologos N, Yuan Y, Liu D, Rademaker A, Yung WK, Vaillant B, Rudnick J, Chamberlain M, Vick N, Grismm S, Tremont-Lukats IW, DeGroot J, Aldape K, Gilbert MR
Journal of Neuro-Oncology
Brain Tumor Trials Collaborative. A Phase II study of Bevacizumab and Erlotinib after Radiation and Temozolomide in MGMT unmethylated GBM patients
Patt D
Journal of Oncology Practice
Better Screening Using Big Data
Jaramillo S, Hui D
Journal of Pain and Symptom management
End-of-Life Care for Undocumented Immigrants with Advanced Cancer: Documenting the Undocumented
Matthew C. Ward , Ankeet Shah, Shlomo A. Koyfman, Tobenna Nwizu, Joseph Scharpf, Brian Burkey, Eric Lamarre, David J. Adelstein, John F. Greskovich, Ping Xia
Journal of Radiation Oncology
The prognostic value of pretreatment FDG-PET parameters in HPV-associated oropharynx cancer
Papasozomenos H, Guha-Thakurta N, Mayer RR, Weinberg JS, Groves MD, Debnam JM
Journal of Solid Tumors
Association between 18F-FDG PET/CT and MRI appearance of spinal leptomeningeal disease before and after treatment at a tertiary referral center
Ashley E. Ross, MD, PhD
Journal of the National Comprehensive Cancer Network
Multigene Testing in Localized Prostate Cancer
Klein EA, Santiago-Jiménez M, Yousefi K, Robbins BA, Schaeffer EM, Trock BJ, Tosoian J, Haddad Z, Ra S, Karnes RJ, Jenkins RB, Cheville JC, Den RB, Dicker AP, Davicioni E, Freedland SJ, Ross AE
Journal of Urology 
Molecular analysis of low grade prostate cancer utilizing a genomic classifier of metastatic potential
Zhao SG, Chang SL, Spratt DE, Erho N, Yu M, Ashab HA, Alshalalfa M, Speers C, Tomlins SA, Davicioni E, Dicker AP, Carroll PR, Cooperberg MR, Freedland SJ, Karnes RJ, Ross AE, Schaeffer EM, Den RB, Nguyen PL, Feng FY
Lancet Oncology
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer:  a matched retrospective analysis
Tosoian JJ, Gorin MA, Ross AE, Pienta KJ, Tran PT, Schaeffer EM
Nature Reviews Urology
Oligometastatic prostate cancer: definitions, clinical outcomes and treatment considerations
Patel K, Sun W.
Oncology
Neoadjuvant Treatment for Surgically Resectable Metastatic Colorectal Cancer: Is There an Optimal Succession?
Woody NM, Koyfman SA, Xia P, Yu N, Shang Q, Adelstein DJ, Scharpf J, Burkey B, Nwizu T, Saxton J, Greskovich JF Jr
Oral Oncology
Regional control is preserved after dose de-escalated radiotherapy to involved lymph nodes in HPV positive oropharyngeal cancer
Matthew C. Ward, David J. Adelstein, Priyanka Bhateja, Tobenna I. Nwizu, Joseph Scharpf, Narcissa Houston, Eric D. Lamarre, Robert Lorenz, Brian B. Burkey, John F. Greskovich, Shlomo A. Koyfman
Oral Oncology
Severe late dysphagia and cause of death after concurrent chemoradiation for larynx cancer in patients eligible for RTOG 91-11
Ross AE, Den RB, Yousefi K, Trock BJ, Tosoian J, Davicioni E, Thompson DJ, Choeurng V, Haddad Z, Tran PT, Trabulsi EJ, Gomella LG, Lallas CD, Abdollah F, Feng FY, Klein EA, Dicker AP, Freedland SJ, Karnes RJ, Schaeffer EM
Prostate Cancer Prostatic Diseases
Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk
 Sprunt, JM, J Lang.
Society of Surgical Oncology
A Matched Pair Cohort Study of the Effect of Neoadjuvant Chemotherapy in Stage I-III Breast Cancer.
Chiu L., Chow R., Popovic M., Navari R.M., Shumway N.M., Chiu N., Lam H., Milakovic M., Pasetka M., Vuong S., Chow E., DeAngelis C.
Support Care Cancer
Efficacy of olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis.
Gardner AK, DeMoya MA, Tinkoff GH, Brown KM, Garcia GD, Miller GT, Zaidel BW, Korndorffer JR, Scott DJ, Sachdeva AK
Surgery
Using Simulation for Disaster Preparedness
Dimou FM, Adhikari D, Mehta HB, Olino K, Riall TS, Brown KM
Surgery
Incidence of Hepaticojejunostomy Stricture after Hepaticojejunostomy
Gardner AK, Willis RE, Dunkin BJ, Van Sickle KR, Brown KM, Truitt MS, Uecker JM, Gentry L, Scott DJ
Surgical Endoscopy
What Do Residents Need to Be Competent Laparoscopic and Endoscopic Surgeons?
Gardner AK, Scott DJ, Willis RE, Van Sickle K, Truitt MS, Uecker J, Brown KM, Marks JM, Dunkin BJ
Surgical Endoscopy
Is Current Surgery Resident and GI Fellow Training Adequate to Pass FES?
Hsu JL, Korndorffer JR Jr, Brown KM
The American Journal of Surgery
Force Feedback Vessel Ligation Simulator in Knot-tying Proficiency Training
Willis RE, Dent DL, Love JD, Kempenich JW, Uecker J, Brown KM, Thomas JS, Gomez PP, Adams AJ, Admire JR, Sprunt JM, Kahrig KM, Wiggins-Dohlvik K.
The American Journal of Surgery
Predicting and Enhancing American Board of Surgery In-Training Examination Performance: Does Writing Questions Really Help?
Perone JA, Fankhauser GT, Adhikari D, Mehta HB, Woods MK, Tyler DS, Brown KM
The American Journal of Surgery
It Depends on Your Perspective: Resident Satisfaction with Operative Experience
Perone JA, Fankhauser GT, Adhikari D, Mehta HB, Woods MB, Strohmeyer JH, Tyler DS, Brown KM
The American Journal of Surgery
Who Did the Case? Perceptions on Residents Operative Participation
Salehi HS, Li H, Merkulov A, Kumavor PD, Vavadi H, Sanders M, Kueck A, Brewer MA, Zhu Q
The Journal of Biomedical Optics
Coregistered Photoacoustic and Ultrasound Imaging and Classification of Ovarian Cancer: Ex Vivo and in Vivo Studies
Brown KM, Geller DA
The Journal of Gastrointestinal Surgery
What Is the Learning Curve for Major Laparoscopic Hepatectomy?

John F. Sandbach
Gayle Patel, Elizabeth King, Brent Evans, John Kidd, Lucy Langer, Krystal L. Brown, Richard Wenstrup, Jennifer Saam

2015 ASCO Annual Meeting
A Study of Triple-Negative Breast Cancer Patients Tested With a 25-Gene Panel of Hereditary Cancer Genes.
Isis Gayed, MD, Robert Amato,MD, Gurjyot Doshi, MD, Mina Fanous,MD, David Wan,MD, Usha Joseph, MD, Steven Canfield, MD.
2015 World Molecular Imaging Congress. Hawaii
“Early experience with Radium 223 Xofigo Therapy in Patients with Prostate Bony Metastases” Poster Presentation
Christopher A. Yasenchak, Andres Forero-Torres, Vivian Jean Mikao Cline-Burkhardt, Rodolfo E Bordoni, Dipti Patel-Donnelly, Patrick J. Flynn, Robert Chen, Abraham Fong and Jonathan W. Friedberg
57th Annual ASH Annual Meeting
Brentuximab Vedotin in combination with Dacarbazine or Bendamustine for frontline Treatment of Hodgkin Lymphoma in patients aged 60 years and above: interim results of a multicohort phase II study.
Kharod SM, Herman MP, Amdur RJ, Mendenhall WM.
American Journal of Clinical Oncology
Fractionated Radiation Therapy for Benign Nonacoustic Schwannomas
Wilks, Sharon T., Yardley, etal.
American Society of Clinical Oncology
Weekly nab-Paclitaxel plus Gemcitabine (Gem) or Carboplatin (Carbo) versus Gem/Carbo as First Line Treatment for Metastatic Triple Negative (mTNBC) in a Phase II/III Trial (TnAcity).
Wilks, Sharon T., Slamon, et al.
American Society of Clinical Oncology
Predictive Biomarkers of Everolimus efficacy in HER2+ Advanced Breast Cancer: Combined Exploratory Analysis from BOLERO-1 and BOLERO-3.
American Society of Hematology
A Retrospective Analysis of Myeloproliferative Neoplasms: Treatment Approach and Outcomes at Drexel University Hospital
Jimeno A, Shirai K, Choi M, Laskin J, Kochenderfer M, Spira A, Cline-Burkhardt V, Winquist E, Hausman D, Walker L, Cohen RB.
Annals of Oncology
A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer.
Manyam BV, Nwizu TI, Rahe ML, Harr BA, Koyfman SA
Anticancer Res.
Early and Severe Radiation Toxicity Associated with Concurrent Sirolimus in an Organ Transplant Recipient with Head and Neck Cutaneous Squamous Cell Carcinoma: A Case Report
Bindu V. Manyam, Tobenna Nwizu, Melissa Rahe, Bridgett Harr, Shlomo Koyfman
Anticancer Research
Early and Severe Radiation Toxicity Associated with Concurrent Sirolimus in an Organ Transplant Recipient with Head and Neck Cutaneous Squamous Cell Carcinoma: A Case Report
Bersabe, Adrian REYES and Osswald, Michael B and Shumway, Nathan M
ASCO Annual Meeting Proceedings
Correlation of peripheral blood smear review and bone marrow biopsies for benign hematology Outpatient referrals.
Greene JM, Schneble EJ, Martin J, Flores M, Berry, Trappey AF, Vreeland TJ, Hale DF, Sears AK, Clifton GT, von Hofe E, Ardavannis A, Shumway N, Ponniah S, Papamichail M, Perez S, Symanowski JT, Peoples GE, Mittendorf EA.
ASCO Annual Meeting Proceedings
Final pre-specified analysis of the phase II trial of the AE37+ GM-CSF vaccine in high risk breast cancer patients to prevent recurrence.
Nandy S, Salehi HS, Wang T, Wang X, Sanders M, Kueck A, Brewer M, Zhu Q
Biomedical Optics Express
Correlating Optical Coherence Elastography Based Strain Measurements with Collagen Content of the Hum Ovarian Tissue
Kathryn Kolibaba, John M. Burke, Heather D. Brooks, Daruka Mahadevan, Jason Melear, Charles M. Farber, Suzanne R. Fanning, Marshall T. Schreeder, Ralph V. Boccia, Peter Sportelli, Hari P. Miskin, Michael S. Weiss and Jeff P. Sharman
Blood
Ublituximab in combination with ibrutinib is highly active in patients with relapsed and/or refractory mantle cell lymphoma. Results of a Phase II trial.
Liang C, Li L, Fraser CD, Ko A, Corzo D, Enger C, Patt D
BMC Cancer
The treatment patterns, efficacy, and safety of nab-paclitaxel for the treatment of metastatic breast cancer in the United States: results from health insurance claims analysis
Zhu XR, Li Y, Mackin D, Li H, Poenisch F, Lee AK, Mahajan A, Frank SJ, Gillin MT, Sahoo N, Zhang X
Cancers
Towards effective and efficient patient-specific quality assurance for spot-scanning proton therapy
O'Brien, B., Koru-Sengul, T., Saclarides, C.
Clinical Breast Cancer
Disparities in Male Breast Cancer - The Florida Experience
Di Bella NJ, Bhowmik D, Bhor M, Yap M, Middlebrook B, Rembert D, Cain Z, Okoro T, Bolinder B, Patt D, Jabbour EJ
Clinical Lymphoma, Myeloma & Leukemia
The Effectiveness of Tyrosine Kinase Inhibitors and Molecular Monitoring Patterns in Newly Diagnosed Patients With Chronic Myeloid Leukemia in the Community Setting
Wilks, S. & McIntyre, K
Clinical Medicine Insights: Oncology
Case Studies in the Management of Metastatic Breast Cancer with Eribulin.
Kennedy WR, Herman MP, Deraniyagala RL, Amdur RJ, Werning JW, Morris CG, Mendenhall WM.
European Archives of Oto-Rhino-Laryngology
Ipsilateral Radiotherapy for Squamous Cell Carcinoma of the Tonsil
Nwizu T, Adelstein D.
Expert Opinion Pharmacotherapy
Pharmacotherapy of head and neck cancer
Hsu, JL, Korndorffer JR Jr., Brown KM
Journal of Surgical Research
Design of a Vessel Ligation Simulator for Deliberate Practice
Silverman E, Tucker SA, Imsdahl S, Charles JA, Stellato MA, Wagner MD, Brown KM
Surgical Clinics of North America
Conducting Elite Performance Training
Paige JT, Garbee DD, Brown KM, Rojas JD
Surgical Clinics of North America
Using Simulation in Interprofessional Education
Al Seesi S, Duan F, Mandoiu II, Srivastava PK, Kueck A
Translational Cardiometabolic Genomic Medicine
Genomics-guided Immunotherapy of Human Epithelial Ovarian Cancer
Dinkelspiel HE, Champer M, Hou J, Tergas AI, Burke WM, Huang Y, Neugut AI, Ananth CV, Hershman DL, Wright JD
Gynecologic Oncology
Long-term mortality among women with epithelial ovarian cancer
Dinkelspiel HE, Tergas AI, Zimmerman LD, Burke WB, Hou J, Chen L, Hillyer G, Neuget A, Hershman D, Wright JD
Gynecologic Oncology
Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer
Tierney C, Dinkelspiel HE, Bass A, Cimic A, Katzen J, Holcomb K
Gynecologic Oncology Reports
Sclerosing mesenteritis mimics gynecologic malignancy
Patel K, Jatoi A.
Handbook of Clinical Nutrition and Aging
Nutrition Support in Solid Tumor Cancer Patients.
Ward MC, Bhateja P, Nwizu T, Kmiecik J, Reddy CA, Scharpf J, Lamarre ED, Burkey BB, Greskovich JF, Adelstein DJ, Koyfman SA
Head Neck
Impact of feeding tube choice on severe late dysphagia after definitive chemoradiotherapy for human papillomavirus-negative head and neck cancer
Mangona VS, Aneese AM, Hymas RV, Marina 0, lonascu D, Gallardo LJ, Yan D, Robertson JM, Grills IS
International Journal of Radiation Oncology, Biology and Physics
Toxicity After Central versus Peripheral Stereotactic Lung Radiotherapy (SBRT): A Propensity Score Matched-Pair Analysis.
V.S. Mangona, D.R. Grosshans, M. Chintagumpala, S. Khatua, N.V. Philip, M.F. McAleer, S.L. McGovern, J. Su, M.F. Okcu, A.C. Paulino, A. Mahajan
International Journal of Radiation Oncology, Biology and Physics
A. Clinical Outcomes of Children with Medulloblastoma After Proton Radiotherapy.
Trosman SJ, Koyfman SA, Ward MC, Al-Khudari S, Nwizu T, Greskovich JF, Lamarre ED, Scharpf J, Khan MJ, Lorenz RR, Adelstein DJ, Burkey BB
JAMA Otolaryngol Head Neck Surg.
Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy
Schadendorf D, Hodi FS, Robert C, Weber JS, Margolin K, Hamid O, Patt D, Chen TT, Berman DM, Wolchok JD
Journal of Clinical Oncology
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
Andre, Fabrice, Sara Hurvitz, Angelica Fasolo, Ling-Ming Tseng, Guy Jerusalem, Sharon Wilks, Ruth O’Regan, Claudine Isaacs, Masakazu Toi, Howard Burris, Wei He, Douglas Robinson, Markus Riester Riester, Tetiana Taran, David Chen and Dennis Salmon
Journal of Clinical Oncology
Molecular Alterations and Everolimus  Efficacy in HER2-Overexpressing Metastatic Breast Cancers: Combined Exploratory Analysis from BOLERO-1 and BOLERO-3.
Shumway, Nathan M and Dacus, Jennifer J and Lathrop, Kate I and Hernandez, Elizabeth P and Miller, Maria and Karnad, Anand B
Journal of Graduate Medical Education
Use of milestones and development of entrustable professional activities in 2 hematology/oncology training programs
Henry NL, Patt DA, Meyers MO, Malik M, Bretsch J, Jackson C, Grupe A, Von Roenn J.
Journal of Oncology Practice
Bridging the Medical Education and Quality Cancer Care Divide: A Call to Action
Shumway, Nathan M and Terrazzino, Sandra E and Jones, Christopher B
Journal of Pain Management
A randomized pilot study comparing olanzapine (Zyprexa) to aprepitant (Emend) for treatment of chemotherapy-induced nausea and vomiting
Denduluri N, Patt DA, Wang Y, Bhor M, Li X, Favret AM, Morrow PK, Barron RL, Asmar L, Saravanan S, Li Y, Garcia J, Lyman GH
Journal of the National Comprehensive Cancer Network
Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices
Stone BS, Mangona VS, Johnson MD, Ye Hong, Grills IS
Journal of Thoracic Oncology
Changes in Pulmonary Function Following Image Guided Stereotactic Lung Radiotherapy: Neither Lower Baseline or Post-SBRT Pulmonary Function are Associated with Worse Overall Survival.
Yasenchak CA, Tseng WY, Yap M, Rembert D, Patt DA
Leukemia & Lymphoma
Economic impact of disease progression following front-line therapy in classical Hodgkin lymphoma
Penas-Prado M, Hess KR, Fisch MJ, Lagrone LW, Groves MD, Levin VA, De Groot JF, Puduvalli VK, Colman H, Volas-Redd G, Giglio P, Conrad CA, Salacz ME, Floyd JD, Loghin ME, Hsu SH, Gonzalez J, Chang EL, Woo SY, Mahajan A, Aldape KD, Yung WKA, Gilbert MR
Neuro-Oncology
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma
Schuster J, Lai RK, Recht LD, Reardon DA, Paleologos NA, Groves MD, Mrugala MM, Jensen R, Baehring JM, Sloan A, Archer GE, Bigner DD, Cruickshank S, Green JA, Keler T, Davis TA, Heimberger AB, Sampson JH
Neuro-Oncology
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
Kinney W, Wright T, Dinkelspiel H, DeFrancesco M, Cox T, Huh W
Obstetrics & Gynecology
Increased cervical cancer risk associated with screening at longer intervals
​Kumar A, Mynderse L, Patel K, Grudem M, Bakkum-Gamez J, Longenbach S, Block
MS, Pitot HC, Garovic V, Weroha SJ, Jatoi A.
Psychooncology
Ureteral obstruction in cancer patients: a qualitative study.
Wilks, S. et al
San Antonio Breast Cancer Symposium
Phase I study of GR antagonist Mifepristone (M) in combination with Eribulin (E)in advanced solid tumors, with dose expansion in patients (pts)with GR-positive Triple Negative Breast Cancer (TNBC).
Schnadig, Ian; Wilks, Sharon T.
San Antonio Breast Cancer Symposium
Phase 3 Comparison of APF530 versus Ondansetron, Each in a Guideline-Recommended 3-drug Regimen for Prevention of Chemotherapy Induced Nausea and Vomiting due to Anthracycline+ Cyclophosphamide (AC) Based Highly Emetogenic Chemotherapy (HEC) Regime.
O’Shaughnessy, J. et al., Wilks Sharon T.
Springer Plus Open Journal Volume 4
Impact of Prior Anthracycline or Taxane on Eribulin Effectiveness as First-Line Treatment for Metastatic Breast Cancer: Results from Two Phase 2, Multicenter, Single-arm Studies.
Patel K, Foster NR, Kumar A, Grudem M, Longenbach S, Bakkum-Gamez J, Haddock M, Dowdy S, Jatoi A.
Support Cancer Care
Hydronephrosis in patients with cervical cancer: an assessment of morbidity and survival.
Wilks, Sharon T.
The Breast
Potential of Overcoming Resistance to HER2-Targeted Therapies through the PI3K/Akt/mTOR pathway.
Patt D, Rembert D, Corzo D.
The Journal of Community and Supportive Oncology
Treatment of Metastatic Breast Cancer with 𝑛𝑎𝑏-paclitaxel in the Community Practice Setting: a US Oncology Survey.
 Brown KM, Geller DA
ACS MultiMedia Atlas of Surgery Liver Surgery
Laparoscopic Resection of Hepatic Cysts
Brown KM, Geller DA
Biliary Tract and Gallbladder Cancer: A Multidisciplinary Approach
Surgical Management of Intra-Hepatic Cholangiocaricnoma
Vargas GM, Parmar AD, Sheffield KM, Tamirisa NP, Brown KM, Riall TS
Journal of Surgical Research
Impact of Liver-directed Therapy in Colorectal Cancer Metastases
Brown KM, Chao C
Surgical Clinics of North America
Melanoma
Brown KM, Parmar AD, Geller DA
Surgical Oncology Clinics of North America
Intrahepatic Cholangiocarcinoma
Brown KM, Geller DA
Surgical Oncology Clinics of North America
Proximal Biliary Tumors
Herman MP, Dagan R, Amdur RJ, Morris CG, Werning JW, Vaysberg M, Mendenhall WM.
The Laryngoscope
Efficacy from Postoperative Radiotherapy for Patients at High Risk for Recurrence following Surgery for Oral Cavity Squamous Cell Carcinoma
Sturgeon JD, Crane CH, Krishnan S, Minsky BO, Skibber JM, Rodriguez-Bigas MA, Chang GJ, You YN, Eng C, Das P.
American Journal of Clinical Oncology
Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum.
Shumway NM, Lathrop KI, Dacus JJ, Miller M, Hernandez EP, Karnad AB
Accreditation Council of Graduate Medical Education
Use Of Milestones And Development Of Entrustable Professional Activities (EPAs) In Hematology/Oncology (HO) Training Programs -- A Proactive And Practical Approach to a New Evaluation System.
Bian SX, Kuban DA, Levy LB, Oh J, Choi S, McGuire SE, Frank SJ, Mahmood U, Nguyen PL, Pugh TJ, Lee AK, Hoffman KE
American Journal of Clinical Oncology
The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer
Shumway, Nathan M and Dacus, Jennifer Jill and Lathrop, Kate Ida and Hernandez, Elizabeth P and Miller, Maria and Karnad, Anand B
ASCO Annual Meeting Proceedings
Informed consent training for medical oncology fellows: Checklist-based simulation exercise.
Dacus, Jennifer Jill and Shumway, Nathan M and Lathrop, Kate Ida and Hernandez, Elizabeth P and Miller, Maria and Karnad, Anand B
ASCO Annual Meeting Proceedings
Chemotherapy infusion reaction training for medical oncology fellows: A checklist-based simulation exercise.
Mittendorf EA, Schneble EJ, Perez S, Symanowski JT, Patil R, Vreeland TJ, Berry JS, Trappey AF, Hale DF, Sears AK, Clifton GT, von Hofe E, Ardavannis A, Ponniah S, Shumway N, Papamichail M, Peoples GE. 
ASCO Annual Meeting Proceedings
Primary analysis of the prospective, randomized, phase II trial of GP2+ GM-CSF vaccine versus GM-CSF alone administered in the adjuvant setting to high-risk breast cancer patients
Erika J Schneble, Sonia A. Perez, John S. Berry, Alfred F Trappey, Tim Vreeland, Diane F. Hale, Alan K. Sears, Guy T. Clifton, Eric von Hofe, Alexandros Ardavanis, Nathan M. Shumway, Sathibalan Ponniah, Michael Papamichail, George Earl Peoples, Elizabeth Ann Mittendorf
ASCO Annual Meeting Proceedings
Comparison of recurrent and nonrecurrent breast cancer patients undergoing AE37 peptide vaccine therapy.
Elizabeth Ann Mittendorf, Erika J Schneble, Sonia A. Perez, James T Symanowski, Ritesh Patil, Timothy J. Vreeland, John S. Berry, Alfred F Trappey, Guy T. Clifton, Eric von Hofe, Alexandros Ardavanis, Sathibalan Ponniah, Nathan M. Shumway, Michael Papamichail, George Earl Peoples
ASCO Annual Meeting Proceedings
Primary analysis of the prospective, randomized, single-blinded phase II trial of AE37 vaccine versus GM-CSF alone administered in the adjuvant setting to high-risk breast cancer patients.
Bersabe, Adrian R and Osswald, Michael and Shumway, Nathan M
Blood
Peripheral Blood Smear Utilization within a Military Hematology/Oncology Fellowship Program
Patel K, Stephens EK, Miller RC, Jatoi A.
Cancer Control
Incidence and outcomes of chemotherapy and radiation in morbidly obese patients with locally advanced lung and esophageal cancers: a single-institution experience.
Pugh TJ, Lee AK
Cancer Journal
Proton beam therapy for the treatment of prostate cancer
Wilks, Sharon et al
Clinical Breast Cancer
Phase 2, Multicenter, Single-Arm Study of Eribulin Mesylate + Trastuzumab as First Line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer.
Dinkelspiel H, Kinney W
Gynecologic Oncology
State of the Science: Cervical cancer screening in transition
Kinney WK, Hunt WC, Dinkelspiel H, Robertson M, Cuzick J, Wheeler CM
Gynecologic Oncology
New Mexico HPV Pap Registry Steering Committee. Cervical excisional treatment of young women: a population-based study
Nwizu T, Adelstein DJ
How much and How Often: Expert Review of Anticancer Therapy
In Squamous Cell Head and Neck Cancer: Which Platinum

Roger M. Lyons

International Blood Research & Reviews
Iron Overload, Chelation Therapy and Survival in Lower-risk Myelodysplastic Syndromes: State of Evidence

Download full publication here.

Sturgeon JD; Cox JA; Mayo LL; Gunn GB; Zhang J; Balter PA; Dong L; Awan M; Kocak-Uzel E; Mohamed AS; Rosenthal DI; Fuller CD.
International Journal of Computer Assisted Radiology and Surgery
Improved human observer performance in digital reconstructed radiograph verification in head and neck cancer radiotherapy.
Hoffman KE, Voong KR, Pugh TJ, Skinner H, Levy LB, Takiar V, Choi S, Du W, Frank SJ, Johnson J, Kanke J, Kudchadker RJ, Lee AK, Mahmood U, McGuire SE, Kuban DA
International Journal of Radiation Oncology
Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial
Graham LJ, Shupe MP, Schneble EJ, Flynt FL, clemenshaw MN, Kirkpatrick AD, Gallagher C, Nissan A, Henry L, Stojadinovic A, Peoples GE, Shumway NM
Journal of Cancer
Current approaches and challenges in monitoring treatment responses in breast cancer
Schneble EJ, Graham LJ, Shupe MP, Flynt FL, Banks KP, Kirkpatrick AD, Nissan A, Henry L, Stojadinovic A, Shumway NM, Avital I, Peoples GE, Setlik RF. 
Journal of Cancer
Current approaches and challenges in early detection of breast cancer recurrence
Shupe, Matthew P and Graham, Lindsey J and Schneble, Erika J and Flynt, Frederick L and Clemenshaw, Michael N and Kirkpatrick, Aaron D and Stojadinovic, Alexander and Peoples, George E and Shumway, Nathan M
Journal of Cancer
Future directions for monitoring treatment responses in breast cancer
Schneble EJ, Graham LJ, Shupe MP, Flynt FL, Banks KP, Kirkpatrick AD, Nissan A, Henry L, Stojadinovic A, Shumway NM, Avital I, Peoples GE, Setlik RF.
Journal of Cancer
Future directions for the early detection of recurrent breast cancer
Ramakrishna N, Temin S, Chandarlapaty S, Crews JR, Davidson NE, Esteva FJ, Giordano SH, Gonzalez-Angulo AM, Kirshner JJ, Krop I, Levinson J, Modi S, Patt DA, Perez EA, Perlmutter J, Winer EP, Lin NU
Journal of Clinical Oncology
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline
Giordano SH, Temin S, Kirshner JJ, Chandarlapaty S, Crews JR, Davidson NE, Esteva FJ, Gonzalez-Angulo AM, Krop I, Levinson J, Lin NU, Modi S, Patt DA, Perez EA, Perlmutter J, Ramakrishna N, Winer EP
Journal of Clinical Oncology
Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Patt DA
Journal of Community and Supportive Oncology
Taking on racial and ethnic disparities in cancer care
Correa-Gallego C, Dinkelspiel HE, Sulimanoff I, Fisher S, Viñuela EF, Kingham TP, Fong Y, DeMatteo RP, D'Angelica MI, Jarnagin WR, Allen PJ
Journal of the American College of Surgeons
Minimally invasive vs. open pancreaticoduodenectomy: systematic review and meta-analysis
Madsen LT, Kuban DA, Choi S, Davis JW, Kim J, Lee AK, Domain D, Levy L, Pisters LL, Pettaway CA, Ward JF, Logothetis C, Hoffman KE
Journal of the National Comprehensive Cancer Network
Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic
Mahmood U, Levy LB, Nguyen PL, Lee AK, Kuban DA, Hoffman KE
Journal of Urology
Current Clinical Presentation and Treatment of Localized Prostate Cancer in the United States

Roger M. Lyons
Billie J. Marek, Carole Paley, Jason Esposito, Lawrence Garbo, Nicholas DiBella, Guillermo Garcia-Manero

Leukemia Research
Comparison of 24-Month Outcomes in Chelated and non-Chelated Lower-risk Patients with Myelodysplastic Syndromes in a Prospective Registry

Download full publication here.

Zhuang L, Yan D, Liang J, lonascu D, Mangona V, Zhou J
Medical Physics
Evaluation of Image Guided Motion Management Methods in Lung Cancer Radiotherapy.
Wen PY, Chang SM, Lamborn KR, Kuhn JG, Norden AD, Cloughesy TF, Robins HI, Lieberman FS, Gilbert MR, Mehta MP, Drappatz J, Groves MD, Santagata S, Ligon AH, Yung WKA, Wright JJ, Dancey J, Aldape KD, Prados MD, Ligon KL
Neuro-Oncology
Phase I/II Study of Erlotinib and Temsirolimus for Patients with Recurrent Malignant Glioma: North American Brain Tumor Consortium Trial 04-02
Chamberlain M, Junck L, Brandsma D, Soffietti R, Ruda R, Raizer J, Boogerd W, Taillibert S, Groves MD, Le Rhun E, Bromberg J, Walker J, van den Bent M, Wen PY, Jaeckle KA
Neuro-Oncology
Leptomeningeal Metastases: A RANO Proposal for Response Criteria
Bates G, Chi D, Khandker M, Dinkelspiel HE, Wright JD, Taub R, Lewin SN
Ninth International Symposium on Regional Cancer Therapies
Intraperitoneal chemotherapy and ileostomies in ovarian cancer.
Wootton L, Kudchadker R, Lee A, Beddar S
Physics in Medicine and Biology
Real-time in vivo rectal wall dosimetry using plastic scintillation detectors for patients with prostate cancer
Dinkelspiel HE, Lewin SN, Tergas AI, Burke WM, Prendergast E, Lu YS, Herzog TJ, Wright JD
Poster presentation at the New York Obstetrics Society Meeting
Long-term mortality among women with epithelial ovarian cancer.
Dinkelspiel HE, Matrai C, Pauk S, Pierre-Louis A, Chiu YL, Gupta D, Caputo TA, Ellenson L, Holcomb KM
Poster presentation at the Society for Gynecologic Oncology 45th Annual Meeting on Women’s Cancer
The presence of endometriosis is associated with improved survival in epithelial ovarian cancer.
Dinkelspiel HE, Zimmerman LD, Lewin SN, Tergas AI, Burke WB, Lu YS, Herzog TJ, Wright JD
Poster presentation at the Society for Gynecologic Oncology 45th Annual Meeting on Women’s Cancer
Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer.
Zhu XR, Poenisch F, Li H, Zhang X, Sahoo N, Wu RY, Li X, Lee AK, Chang EL, Choi S, Pugh T, Frank SJ, Gillin MT, Mahajan A, Grosshans DR
Radiation Oncology
A single-field integrated boost treatment planning technique for spot scanning proton therapy

John Sandbach
Sami Diab, Patricia Rodriguez, Anna Leininger, Lisa Clarke, Mike F. Janicek, Ellen B. Smith, Jennifer Saam, Lucy Langer

San Antonio Breast Cancer Symposium
Experience in the Community Oncology Practice with a 25-Gene Hereditary Cancer Panel
Wilks, Sharon T., Andre, Fabrice, etal
The Lancet Oncology
Everolimus for Women with Trastuzumab Resistant, HER2 Positive, Advanced Breast Cancer (BOLERO-3): A Randomized, Double Blind, Placebo Controlled Phase III Trial.
O'Brien, B. DeLuca, J., Dyer, B., Richmond, B. 
West Virginia Medical Journal
Gallbladder Carcinoma in a Patient with Streptococcus bovis Bacteremia

Roger Lyons
Uwe Platzbecker, Raymond SM Wong, Amit Verma, Camille Abboud, Sergio Araujo, Tzeon-Jye Chiou, John Feigert, Su-Peng Yeh, Katharina Götze, Norbert-Claude Gorin, Peter Greenberg, Suman Kambhampati, Yoo-Jin Kim, Je-Hwan Lee, Marco Ruggeri, Valeria Santini, Gregory Cheng, Jun Ho Jang, Chien-Yuan Chen, Souria Dougherty, Frank Mannino, Yasser Mostafa Kamel, Geoffrey Chan, Michael Arning, Nicole Stone, Aristoteles Giagounidis

18th Congress of the European Hematology Association
Placebo-controlled, Randomized, Phase I/II Trial of the Thrombopoeitin Receptor Agonist Eltrombopag in Thrombocytopenic Patients with Advanced Myelodysplastic Syndromes or Acute Myeloid Leukemia

Download full publication here.

John F. Sandbach, MD
Joyce O’Shaughnessy, MD; David Loesch, MD; Devchand Paul, DO, PhD; Christopher T. Stokoe, MD; John E Pippen, Jr., MD; Joanne L. Blum., MD, PhD; Lea K. Krekow, MD; Frankie Ann Holmes, MD; Svetislava J. Vukelja, MD; Deborah Lindquist, MD; Scot M. Sedlacek, MD; Yunfei Wang, PhD; Stephen Jones, MD.

 

2013 ASCO Annual Meeting
ER as a Predictor of Early Breast Cancer (EBC) Outcomes in Patients ≤ 40 Years.

Roger M. Lyons, MD
Gary E Raskob, PhD, Harry Buller, MD, PhD, Pantep Angchaisuksiri, MD, Doyeun Oh, MD, PhD, Zoltan Boda, MD, PhD, DSc, Jeffrey I. Weitz, MD, George Zhang, PhD, Hans J Lanz, MD, Michele Mercuri,
MD, PhD, FAHA

55th American Society of Hematology Annual Meeting and Exposition
Edoxaban for Long-Term Treatment of Venous Thromboembolism in Cancer Patients 

Download full publication here.

Roger M. Lyons, MD
Srdan Verstovsek, MD, PhD, Ruben A. Mesa, MD, Jason Gotlib, MD, MS, Richard S. Levy, MD, Vikas Gupta, MD, FRCP, FRCPath, John F. Dipersio, MD, PhD, John V. Catalano, MD, Michael W. Deininger, MD, PhD, Carole B. Miller, MD, Richard T. Silver, Moshe Talpaz, MD, Elliott F. Winton, MD, Jimmie H. Harvey Jr., MD, Murat O. Arcasoy, MD, Elizabeth Hexner, MD, Ronald Paquette, MD, Azra Raza, MD, Kris Vaddi, PhD, William Sun, PhD, Wei Peng, PhD, Victor A. Sandor, MD, CM, Hagop M. Kantarjian, MD

55th American Society of Hematology Annual Meeting and Exposition
Long-Term Outcomes of Ruxolitinib Therapy in Patients with Myelofibrosis: 3-Year Update From COMFORT-1

Download full publication here.

Roger M. Lyons, MD
Paul J. Shaughnessy, MD, Ann Kelley, RN, Roberta Tremper, RN, Jonathan Tinker, Carlos Bachier, MD, Joseph Holahan, MD, Charles F. LeMaistre, MD

55th American Society of Hematology Annual Meeting and Exposition
The VIP (Very Immunocompromised Patient ) Protocol: Improved Access to Care and Time to Antibiotics

Download full publication here.

Roger M. Lyons
Uwe Platzbecker, MD, PhD, Raymond S.M. Wong, Amit Verma, MD, Camille N. Abboud, MD, Sergio Araujo, Tzeon-Jye Chiou, MD, John Feigert, MD, Su-Peng Yeh, MD, Katharina Götze, M.D., Norbert Claude Gorin, MD, PhD, Peter L. Greenberg, MD, Suman Kambhampati, MD, Yoo Jin Kim, MD, Je-Hwan Lee, Marco Ruggeri, MD, Valeria Santini, MD, Gregory Cheng, Jun Ho Jang, Chien-Yuan Chen, Souria Hasan Dougherty, Frank Mannino, Yasser Mostafa Kamel, Geoffrey W. Chan, MD, Nicole L. Stone, PhD, Aristoteles Giagounidis, MD

55th American Society of Hematology Annual Meeting and Exposition
Randomized, Placebo-Controlled, Phase I/II Trial of the Thrombopoietin Receptor (TPO-R) Agonist Eltrombopag in Thrombocytopenic Patients with Advanced Myelodysplastic Syndromes or Acute Myeloid Leukemia—A Subgroup Analysis of Patients Receiving Concomitant Anticancer Therapy

Download full publication here.

Roger M. Lyons, MD
Billie J. Marek, MD, Carole S. Paley, MD, Jason Esposito, MSHS, Katie McNamara, MSHS, CCRA, Lawrence Garbo, MD, Nicholas DiBella, MD, Guillermo Garcia-Manero, MD

55th American Society of Hematology Annual Meeting and Exposition
48-Month Update on Survival and AML Transformation in a 600-Patient Registry of Lower-Risk MDS Patients

Download full publication here.

Vargas GM, Parikh P, Brown KM
ACS Surgery: Principles and Practice Online
Tumors of the Liver and Biliary Tract
Muren L, Rossi C, Hug E, Lee AK, Glimelius B
Acta Oncologica
Establishing and expanding the indications for proton and particle therapy
Herman MP, Werning JW, Morris CG, Kirwan JM, Amdur RJ, Mendenhall WM.
American Journal of Otolaryngology
Elective neck management for high-grade salivary gland carcinoma
King HM, et al.
American Society of Breast Surgeons
Breast Cancer Reconstruction in the State of Florida: Trends in Immediate versus Delayed Surgery and Implant versus Autologous Techniques.
Reeder-Hayes K, Felip E, Patt D, Jaffee E
American Society of Clinical Oncology Educational Book
Women in Oncology: Progress, Challenges, and Keys to Success.
Van Buren G, Bloomston M, Hughes SJ, Winter J, Behrman SW, Zyromski NJ, Vollmer C, Velanovich V, Riall TS, Muscarella P, Trevino J, Nakeeb A, Schmidt CM, Behrns K, Ellison C, Barakat O, Perry KA, Brebin J, House M, Abdel-Misih S, Silberfein EJ, Goldin S, Brown KM, Mohammed S, Hodges, McElhany A, Issazadeh M, Jo E, Mo Q, Fisher WE
Annals of Surgery
A Randomized Prospective Multicenter Trial of Pancreaticoduodenectomy with and without Routine Intraperitoneal Drainage
Vreeland, TJ and Berry, JS and Trappey, AF and Hale, D and Clifton, GT and Sears, A and Shumway, NM and Holmes, JP and Ponniah, S and Mittendorf, EA and others
Annals Of Surgical Oncology
Use of an Attenuated Version of a Strongly Immunogenic, Peptide-based Vaccine to Enhance an Anti-cancer Immune Response against Folate Receptor-alpha (FR alpha)
Morosky C, Kueck A, Trymbulak W.
APGO Martin L. Stone, MD Faculty Development Seminar, "APOG Five-O: Journey to our Future."
Hospital-wide EMR: The Downfall of the Student Note?
Patil, Ritesh and Clifton, Guy T and Litton, Jennifer Keating and Shumway, Nathan M and Vreeland, Timothy J and Berry, John S and Trappey, Alfred F and Ponniah, Sathibalan and Peoples, George Earl and Mittendorf, Elizabeth Ann
ASCO Annual Meeting Proceedings
Safety and efficacy of the HER2-derived GP2 peptide vaccine in combination with trastuzumab for breast cancer patients in the adjuvant setting.
Trappey, Alfred F and Berry, John S and Vreeland, Timothy J and Hale, Diane F and Sears, Alan K and Ponniah, Sathibalan and Perez, Sonia A and Clifton, Guy T and Papamichail, Michael and Shumway, Nathan M and others
ASCO Annual Meeting Proceedings
Risk factors for development of delayed urticarial reactions in the phase II trial of HER2 peptide vaccines plus GM-CSF versus GM-CSF alone in high-risk breast cancer patients to prevent recurrence.

Vivian Jean M. Cline-Burkhardt, M.D. 
J. Randolph Hecht, Allen Lee Cohn, Shaker R. Dakhil, Mansoor N. Saleh, Bilal Piperdi, Ying Tian, William Y. Go

ASCO University
SPIRITT (study 20060141): A randomized phase II study of FOLFIRI with either panitumumab (pmab) or bevacizumab (bev) as second-line treatment (tx) in patients (pts) with wild-type (WT) KRAS metastatic colorectal cancer (mCRC).
Mahmood U, Pugh T, Frank S, Levy L, Walker G, Haque W, Koshy M, Graber W, Swanson D, Hoffman K, Kuban D, Lee A
Brachytherapy
Declining use of brachytherapy for the treatment of prostate cancer

Roger M. Lyons
Srdan Verstovsek, Ruben A. Mesa, Jason Gotlib, Richard S. Levy, Vikas Gupta, John F. DiPersio, John V. Catalano, Michael Deininger, Carole Miller, Richard T. Silver, Moshe Talpaz,11 Elliott F. Winton, Jimmie H. Harvey Jr, Murat O. Arcasoy, Elizabeth Hexner, Ronald Paquette, Azra Raza, Kris Vaddi, Susan Erickson-Viitanen, William Sun, Victor Sandor, Hagop M. Kantarjian

British Journal of Haematology
The Clinical Benefit of Ruxolitinib Across Patient Subgroups: Analysis of a Placebo-controlled, Phase III Study in Patients with Myelofibrosis

Download full publication here.

Roger M Lyons
DJ Kuter, JB Bussel, A Newland, RI Baker, J Wasser, JF Viallard, G Macik, M Rummel, K Nie, S Jun.

British Journal of Haematology
Long-Term Treatment with Romiplostim in Patients with Chronic Immune Thrombocytopenia (ITP): Safety and Efficacy
Yust-Katz S, Liu D, Yuan Y, Liu V, Kang S, Groves M, Puduvalli V, Levin V, Conrad C, Colman H, Hsu S, Yung WK, Gilbert MR
Cancer
Phase I/Ib Study of Lonafarnib and Temozolomide in Patients with Recurrent or Temozolomide Refractory Glioblastoma
A Rojas-Martinez, AG Manzanera, SW Sukin, J Esteban-Maria, JF Gonzalez-Guerrero, L Gomez-Guerra, R Garza-Guajardo, JP Flores-Guterrez, G Elizondo Riojas, I Delgardo-Enciso, R Ortiz-Lopez, LK Aguilar, EB Butler, HA Barrera-Saldana, and E Aguilar-Cordova
Cancer Gene Therapy
Intraprostatic distribution and long-term follow-up after AdV-tk immunotherapy as neoadjuvant to surgery in patients with prostate cancer
Trappey, AF and Berry, JS and Vreeland, TJ and Guy, CT and Diane, HF and Alan, SK and Erika, SJ and Ferrise, L and Shumway, NM and Papamichail, M and others
Cancer Research
Abstract P4-13-05: HLA-A2 is not a prognostic indicator in breast cancer: Implications for cancer vaccine trials
Berry, John S and Trappey, Alfred F and Vreeland, Timothy J and Hale, Diane F and Clifton, Guy T and Sears, Alan K and Shumway, Nathan M and Ponniah, Sathibalan and Holmes, Jarrod P and Ioannides, Constantin and others
Cancer Research
Use of an attenuated version of a strongly immunogenic, peptide-based vaccine to enhance an anti-cancer immune response against folate receptor-alpha.
Vreeland, TJ and John, BS and Trappey, AF and Schneble, EJ and Hale, DF and Clifton, GT and Shumway, NM and Perez, SA and Papamichail, M and Ponniah, S and others
Cancer Research
Breast cancer patients with HER2 low-expression: An under-recognized group at significant risk for recurrence
Berry, JS and Trappey, AF and Vreeland, TJ and Schneble, EJ and Clifton, GT and Hale, DF and Sears, AK and Ponniah, S and Shumway, NM and Mittendorf, EA and others
Cancer Research
Preliminary results for the phase 1 trial of a dual HER2 peptide cancer vaccine in breast and ovarian cancer patients
Reardon DA, Groves MD, Wen PY, Nabors L, Mikkelsen T, Rosenfeld S, Raizer J, Barriuso J, McLendon R, Suttle AB, Ma B, Curtis M, Dar MM, de Bono J
Clinical Cancer Research
A Phase I/II Trial of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma
Drappatz J, Brenner A, Wong ET, Eichler A, Schiff D, Groves MD, Mikkelsen T, Rosenfeld S, Sarantopoulos J, Meyers CA, Fielding RM, Elian K, Wang X, Lawrence B, Shing M, Kelsey S, Castaigne JP, Wen PY
Clinical Cancer Research
Phase I study of GRN1005 in recurrent malignant glioma
Baschnagel A, Mangona V, Robertson J, Welsh R, Kestin L, Grills I
Clinical Oncology
Lung Metastases Treated with Image-guided Stereotactic Body Radiation Therapy.

Roger M. Lyons
Deirdra R. Terrell, PhD, James N. George, MD, James B. Bussel, MD, MD, FACP, Vinod Pullarkat, MD, Robert L. Redner, MD, Dominik Selleslag, MD, Kun Nie, PhD, Paul Woodard, MD

Community Oncology
Self-Administration of Romiplostim in Patients with Chronic Immune Thrombocytopenia (ITP)

Download full publication here.

Herzog TJ, Dinkelspiel HE
Current Oncology
Fallopian tube removal: "stic-ing" it to ovarian cancer: what is the utility of prophylactic tubal removal?
Dinkelspiel H, Fetterman B, Poitras N, Kinney WK, Cox JT, Lorey T, Castle PE
Journal of Lower Genital Tract Disease
Cervical cancer rates after the transition from annual Pap to 3-year HPV and Pap
Nwizu T, Adelstein DJ
Expert Clinical Perspective on Diagnosis & Management of Cancer Analysis of Controversies & Uncertainties in Cancer
Head and Neck Cancer

Debra A. Patt, M.D. 
Clara Chen, M.S., Rahul Dhanda, Ph.D., Wan-Yu Tseng, M.S., Michael Forsyth, R.Ph., M.B.A

American Society of Clinical Oncology
Evaluating Use Characteristics for the Oncotype Dx 21-Gene Recurrence Score and Concordance With Chemotherapy Use in Early-Stage Breast Cancer

Download full publication here.

Roger M. Lyons
Andres Siulnik, Vikas Gupta, Mahmudul Khan, John F. DiPersio, Mari McQuitty, John V. Catalano, Deborah S. Hunter, Laurent Knoops, Michael Deininger, Francisco Cervantes, Carole Miller, Alessandro M. Vannucchi, Richard T. Silver, Tiziano Barbui, Moshe Talpaz, Giovanni Barosi, Elliott F. Winton, Estella Mendeson, Jimmie H. Harvey, Jr, Murat O. Arcasoy, Elizabeth Hexner, Richard Levy, Ronald Paquette, Azra Raza, William Sun, Victor Sandor, Hagop M. Kantarjian, Claire Harrison

Haematologica
Comparison of Placebo and Best Available Therapy for the Treatment of Myelofibrosis in the Phase 3 COMFORT Studies

Download full publication here.

Roger M. Lyons
Richard S. Levy, Srdan Verstovsek, Ruben A. Mesa, Jason Gotlib, Vikas Gupta, John F. DiPersio, John V. Catalano, Michael W.N. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, Elliott F. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Ronald Paquette, Azra Raza, Kris Vaddi, Susan Erickson-Viitanen, William Sun, Victor Sandor, and Hagop M. Kantarjian

Haematologica
Efficacy, Safety and Survival with Ruxolitinib Treatment in Patients with Myelofibrosis: Results of a Median 2-year Follow-up of COMFORT-1

Download full publication here.

Al-Khudari S, Guo S, Chen Y, Nwizu T, Greskovich JF, Lorenz R, Burkey BB, Adelstein DJ, Koyfman SA
Head and Neck
Solitary dural metastasis at presentation in a patient with untreated human papillomavirus associated squamous cell carcinoma of the oropharynx
Li X, Quan EM, Li Y, Pan X, Zhou Y, Wang X, Du W, Kudchadker RJ, Johnson JL, Kuban DA, Lee AK, Zhang X
International Journal of Radiation Oncology
A Fully Automated Method for CT-on-Rails-Guided Online Adaptive Planning for Prostate Cancer Intensity Modulated Radiation Therapy
Park PC, Cheung JP, Zhu XR, Lee AK, Sahoo N, Tucker SL, Liu W, Li H, Mohan R, Court LE, Dong L
International Journal of Radiation Oncology
Statistical Assessment of Proton Treatment Plans under Setup and Range Uncertainties
Winey B, Shih B, Sahoo N, Lee A, Vapiwala N, Both S
International Journal of Radiation Oncology
Core Physics Competencies for Proton Therapy Training of Radiation Oncology and Medical Physics Residents and Fellows
Pugh TJ, Munsell MF, Choi S, Nguyen QN, Mathai B, Zhu XR, Sahoo N, Gillin M, Johnson JL, Amos RA, Dong L, Mahmood U, Kuban DA, Frank SJ, Hoffman KE, McGuire SE, Lee AK
International Journal of Radiation Oncology
Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer
Schneble, Erika J and Berry, John S and Trappey, Alfred F and Vreeland, Timothy J and Hale, Diane F and Sears, Alan K and Clifton, Guy T and Ponniah, Sathibalan and Shumway, Nathan M and Mittendorf, Elizabeth A and others
Journal for Immunotherapy of Cancer
Vaccine-specific T-cell proliferation in response to a dual peptide cancer vaccine in breast and ovarian cancer patients.
Patel K, Foster NR, Farrel A, Le-Lindqwister NA, Leach, J, Costello B, Reynolds J, Meyers J, Jatoi A.
Journal of Cancer Education
Oral cancer chemotherapy adherence and adherence assessment tools: a report from North Central Cancer Group Trial N0747 and a systematic review of the literature.

Roger M Lyons
Billie J. Marek, Carole S. Paley, Jason Esposito, Lawrence E. Garbo, Nicholas J. DiBella, Guillermo Garcia-Manero

Journal of Clinical Oncology
A 36-Month Analysis of Treatment Patterns of Outcomes in Patients with Lower-Risk Myelodysplastic Syndromes from a Prospective Observational Study

Download full publication here.

Journal of Gastrointestinal Oncology
Cholangiocarcinoma: Treatment with Sorafenib Extended Life Expectancy to Greater than Four Years
Vargas GM, Sheffield KM, Parmar AD, Han Y, Gajjar A, Brown KM, Riall TS
Journal of Gastrointestinal Surgery
Trends in the Treatment and Survival in Older Patients Presenting with Stage IV Colorectal Cancer

Roger M Lyons
Moshe Talpaz, Ronald Paquette, Lawrence Afrin, Solomon I Hamburg, Josef T Prchal, Katarzyna Jamieson, Howard R Terebelo, Gregory L Ortega, Ramon V Tiu, Elliott F Winton11, Kavita Natrajan, Olatoyosi Odenike, David Claxton, Wei Peng, Peter O’Neill, Susan Erickson-Viitanen, Lance Leopold, Victor Sandor, Richard S Levy, Hagop M Kantarjian, Srdan Verstovsek

Journal of Hematology & Oncology
Interim Analysis of Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Count

Download full publication here.

Roger M. Lyons
Moshe Talpaz, Ronald Paquette, Lawrence Afrin, Solomon I Hamburg, Josef T Prchal, Katarzyna Jamieson, Howard R Terebelo, Gregory L Ortega, Ramon V Tiu, Elliott F Winton, Kavita Natrajan, Olatoyosi Odenike, David Claxton, Wei Peng, Peter O’Neill, Susan Erickson-Viitanen, Lance Leopold, Victor Sandor, Richard S Levy, Hagop M Kantarjian, Srdan Verstovsek

Journal of Hematology & Oncology
Interim Analysis of Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Counts

Download full publication here.

Yust-Katz S, Garciarena P, Liu D, Yuan Y, Ibrahim N, Yerushalmi R, Penas-Prado M, Groves MD
Journal of Neuro-Oncology
Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis
Anderson MD, Theeler BJ, Penas-Prado M, Groves MD, Yung WK
Journal of Neuro-Oncology
Bevacizumab use in disseminated choroid plexus papilloma
Chen, C, Dhanda, R, Tseng, W, Forsyth, M, Patt, D
Journal of Oncology Practice
Evaluating Use Characteristics for the Oncotype DX 21-gene recurrence score and concordance with chemotherapy use in early stage breast cancer
Riall TS, Brown KM
Journal of Surgical Research
Individualizing Care for Locoregional Pancreatic Cancer?
Brow M, Hoverman JR, Patt D, Herman B, Verrilli D, Garey J, Beveridge R
Journal of the National Comprehensive Cancer Network
Defining cancer care quality or delivering quality cancer care?
Pugh TJ, Amos RA, John Baptiste S, Choi S, Nhu Nguyen Q, Ronald Zhu X, Palmer MB, Lee AK
Medical Dosimetry
Multifield optimization intensity-modulated proton therapy (MFO-IMPT) for prostate cancer: Robustness analysis through simulation of rotational and translational alignment errors
Pair ML, Du W, Rojas HD, Kanke JE, McGuire SE, Lee AK, Kuban DA, Kudchadker RJ
Medical Dosimetry
Dosimetric Effects of Weight Loss or Gain During Volumetric-Modulated Arc Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer
Yust-Katz S, Mathis S, Groves MD
Medical Oncology
Leptomeningeal metastases from genitourinary cancer: The University of Texas MD Anderson Cancer Center experience
Zhou J, Sebastian E, Mangona V, Yan D
Medical Physics
Real-time catheter tracking for high-dose-rate prostate brachytherapy using an electromagnetic 3D-guidance device: A preliminary performance study.
Li H, Sahoo N, Poenisch F, Suzuki K, Li Y, Li X, Zhang X, Lee AK, Gillin MT, Zhu XR
Medical Physics
Use of treatment log files in spot scanning proton therapy as part of patient-specific quality assurance
Dinkelspiel HE, Wright JD, Lewin SN, Herzog TJ
Obstetrics and Gynecology International
Contemporary clinical management of endometrial cancer
Kueck AS*, Kand JH*, Stevens R, Curhan G, DeVivo I, Rosner B, Alexander E, Tworoger SS.
Obstetrics and Gynecology International
A Large Cohort Study of Hypothyroidism and Hyperthyroidism in Relation to Gynecologic Cancers
Ramsey SD, Sullivan SD, Reed SD, Tina Shih YC, Schaecher K, Dhanda R, Patt D, Pendergrass K, Walker M, Malin J, Schwartzberg L, Neumann K, Yu E, Ravelo A, Small A. 
Oncologist
Oncology comparative effectiveness research: a multistakeholder perspective on principles for conduct and reporting

Vivian J.M. Cline-Burkhardt 
Tyvin A Rich,Kathryn Winter,Howard Safran,John P. Hoffman,Beth Erickson,Pramila R. Anne,Robert J. Myerson,Kimberly Perez,Christopher Willett

OncoTargets and Therapy
Paclitaxel, gemcitabine, irradiation, and R115777 for pancreas cancer

Download full publication here.

Dinkelspiel HE, Iyer A, Lefebvre C, Wright JD, Lewin SN, Herzog TJ, Kitajewski J, Califano A. 
Oral Plenary presentation at the Society for Gynecologic Oncology 44th Annual Meeting on Women’s Cancer
​Identification of master regulators of platinum resistance in ovarian cancer.
Dinkelspiel HE, Wright JD, Lewin SN, Herzog TJ
Oral presentation at Columbia University College of Physicians and Surgeons Grand Rounds
Fallopian tube origin of ovarian cancer: salpingectomy in benign gynecologic surgery.
Dinkelspiel HE, Zimmerman LD, Lewin SN, Tergas AI, Burke WB, Lu YS, Herzog TJ, Wright JD
Poster presentation at the New York Obstetrics Society Meeting
Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer.
Melancon AD, Lee AK, Kudchadker R, Zhang L, Tucker S, Kuban D, Dong L
Practical Radiation Oncology
Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiation therapy for prostate cancer
Cerne JZ, McGuire SE, Grant SR, Munsell MF, Lee AK, Kudchadker RJ, Choi SL, Mahmood U, Hoffman KE, Pugh TJ, Frank SJ, Kuban DA
Prostate Cancer and Prostatic Diseases
Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients
Wilks, Sharon, et al.
San Antonio Breast Cancer Symposium
Phase 2, Multicenter, Single-Arm Study of Eribulin Mesylate + Trastuzumab as First Line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer.
Zhang L, Ridgway LD, Wetzel MA, Ngo J, Yin W, Kumar D, Goodman JC, Groves MD, Marchetti D
Science Translational Medicine
The identification and characterization of breast cancer CTCs competent for brain metastasis
Prescott AT, King HM, Ambros T, Villasboas J, Moller M, Hurley J.
Society of Surgical Oncology
The Effect of Surgical Intervention and Ductal Carcinoma In Situ on the Durability of Pathologic Complete Response in Locally Advanced Breast Cancer Treated with Neoadjuvant Therapy: Does the Type of Surgery Affect Survival?
King HM, et al.
Society of Surgical Oncology
Demographic Influences in Breast Reconstruction after Oncologic Surgery in the State of Florida.
Jinkins LJ, Parmar AD, Han Y, Duncan CB, Sheffield KM, Brown KM, Riall TS
Surgery
Current Trends in Preoperative Biliary Stenting in Patients with Pancreatic Cancer
Vargas GM, Sheffield KM, Parmar AD, Brown KM, Riall TS
Surgery
Physician Follow-up and Observation of Guidelines in the Post Treatment Surveillance of Colorectal Cancer
Hafford Ml, Van Sickle KR, Willis RE, Wilson TD, Gugliuzza K, Brown KM
Surgical Endoscopy
Ensuring Competency: Are Fundamentals of Laparoscopic Surgery Training and Certification Necessary for Practicing Surgeons and Operating Room Personnel? 
Brown KM, Moore BT, Sorensen GB, Boettger CH, Tang FM, Jones PG, Margolin DJ
Surgical Endoscopy
Patient-reported Outcomes after Single-incision Versus Traditional Laparoscopic Cholecystectomy: A Randomized, Prospective Trial

Joyce O’Shaughnessy, MD
Linda Vahdat, MD, Lee Schwartzberg, MD, Sharon Wilks, MD, FACP, Jessicca Rege, PhD, Wenquan Wang, PhD, David Cox, PhD

35th Annual San Antonio Breast Cancer Symposium
Eribulin Mesylate with Trastuzumab as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2)-Positive Breast Cancer: Preliminary Results from a Phase 2, Multicenter, Single-Arm Study

Download full publication here.

Roger M. Lyons, MD
Srdan Verstovsek, MD, PhD, Ruben A. Mesa, Jason Gotlib, Richard S. Levy, MD, Vikas Gupta, MD, FRCP, FRCPath, John F. DiPersio, MD, PhD, John V. Catalano, MD, Michael W.N. Deininger, MD, PhD, Carole B. Miller, MD, Richard T. Silver, MD, Moshe Talpaz, MD, Elliott F. Winton, MD, Jimmie H. Harvey, Jr., MD, Murat O. Arcasoy, MD, Elizabeth O. Hexner, MD, Ronald Paquette, MD, PhD, Azra Raza, MD, Kris Vaddi, PhD, Susan Erickson-Viitanen, PhD, William Sun, PhD, Victor A. Sandor, MD, CM, Hagop M. Kantarjian, MD

54th Annual Meeting of the American Society of Hematology
Long-Term Outcome of Ruxolitinib Treatment in Patients with Myelofibrosis: Durable Reductions in Spleen Volume, Improvements in Quality of Life, and Overall Survival Advantage in COMFORT-1

Download full publication here.

Roger M Lyons, MD
Billie J. Marek, MD, Carole Paley, MD, Jason Esposito, MSHS, Lawrence Garbo, MD, Nicholas DiBella, MD, Guillermo Garcia-Manero, MD

54th Annual Meeting of the American Society of Hematology
Relationship Between Chelation and Clinical Outcomes in 600 Lower-Risk MDS Patients: Registry Analysis At 36 Months

Download full publication here.

Roger M Lyons, MD
Sharon T. Wilks, MD, David J. Friedman, MD, PhD, Shelby A Young, RN, BSN, Gail Brown, MD

54th Annual Meeting of the American Society of Hematology
Oral Ezatiostat HCL (Telintra), a Glutathione Analog Prodrug GSTP-1Inhibitor, for Treatment of Patients with Myeloid Growth Factor-Resistant Idiopathic Chronic Neutropenia

Download full publication here.

Roger M. Lyons, MD
Douglas B. Cines, MD, Terry B. Gernsheimer, MD, Jeffrey Wasser, MD, Bertrand Godeau, MD, Andrew Provan, MD, Ivy Altomare, Xuena Wang, PhD, Paul Woodard, MD

54th Annual Meeting of the American Society of Hematology
Integrated Analysis of Long-Term Safety in Patients with Chronic Immune Thrombocytopenia Treated with Romiplostim

Download full publication here.

Roger M. Lyons
Moshe Talpaz, Ronald Paquette, Lawrence Afrin, Solomon Hamburg, Katarzyna Jamieson, Howard Terebelo, Gregory Ortega, Ramon V. Tiu, Elliott F. Winton, Kavita Natrajan, Olatoyosi Odenike, Wei Peng, Victor A. Sandor, Peter O'Neill, Sue Erickson-Viitanen, Lance Leopold, Richard S Levy, Hagop M Kantarjian, Srdan Verstovsek

54th Annual Meeting of the American Society of Hematology
Efficacy, Hematologic Effects, and Dose of Ruxolitinib in Myelofibrosis Patients with Low Starting Platelet Counts (50-100 x 10^9/L): A Comparison to Patients with Normal or High Starting Platelet Counts

Download full publication here.

Hale DF, Vreeland TJ, Dabney RS, Clifton GT, Sears AK, Pappou E, Anastosopoulou E, Ardavanis A, Ponniah S, Papamichail M, Perez S, Shumway N, Peoples GE, Mittendorf E.
American Association for Cancer Research AACR
Abstract LB-218: Immune response assessment in a phase II trial of AE37 HER2 peptide vaccine

Roger M Lyons

American Journal of Medicine
Myelodysplastic Syndromes: Therapy and Outlook

Download full publication here.

Richmond, B., O'Brien, B.
American Surgeon
The Impact of the Implementation of the Bethesda System for Reporting Thyroid Cytopathology on the Surgical Treatment of Thyroid Nodules
Bian SX, Kuban DA, Levy LB, Oh J, Castle KO, Pugh TJ, Choi S, McGuire SE, Nguyen QN, Frank SJ, Nguyen PL, Lee AK, Hoffman KE
Annals of Oncology
Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer
Benarroch-Gampel J, Sheffield KM, Duncan CB, Brown KM, Han Y, Townsend CM Jr, Riall TS
Annals of Surgery
Preoperative Laboratory Testing in Patients Undergoing Elective, Low-risk Ambulatory Surgery
Peterson D, Seils D, Tantawy T, Kueck A, Roberts K
Annual Meeting of the Society of American Gastrointestinal and Endoscopic Surgeons
Novel Method for Comprehensively Assessing the Biomechanical Risks Associated with the Use of Minimally-Invasive Surgical Instruments
Tantawy T, Seils D, Kueck A, Roberts K, Peterson D
Annual Meeting of the Society of American Gastrointestinal and Endoscopic Surgeons
Review of Surgical Ergonomics Research Associated with Minimally Invasive Surgery
Seils D, Tantawy T, Kueck A, Roberts K, Peterson D.
Annual Meeting of the Society of American Gastrointestinal and Endoscopic Surgeons
Comparing the Biomechanical Characteristics of Manual and Powered Laparoscopic Stapler Designs
Shumway, Nathan M and Struble, Erika J
ASCO Annual Meeting Proceedings
Prospective survey study regarding the implementation of new communication skills curriculum for medical oncology trainees.
Diane F Hale, Sonia A. Perez, Timothy J Vreeland, Alfred F Trappey, Raetasha Sheavette Dabney, John S. Berry, Alexandros Ardavanis, Alan K. Sears, Michael Papamichail, Guy T. Clifton, Efi Pappou, Ritesh Patil, Eleftheria Anastasopoulou, Sathibalan Ponniah, Nathan M. Shumway, George Earl Peoples and Elizabeth Ann Mittendorf 
ASCO Annual Meeting Proceedings
An assessment of disease features and immune response in breast cancer patients that did not recur after receiving HER2 peptide, AE37 vaccine in a randomized phase II trial.
Mittendorf, Elizabeth Ann and Perez, Sonia A and Hale, Diane F and Vreeland, Timothy J and Sears, Alan K and Clifton, Guy T and Ardavanis, Alexandros and Shumway, Nathan M and Murray, James L and Ponniah, Sathibalan and others
ASCO Annual Meeting Proceedings
Early efficacy analysis of the AE37 vaccine in patients with HER2 low-expressing and triple-negative breast cancer.
Dabney, Raetasha Sheavette and Hale, Diane F and Vreeland, Timothy J and Clifton, Guy T and Sears, Alan K and Patil, Ritesh and Ponniah, Sathibalan and Shumway, Nathan M and Peoples, George Earl and Mittendorf, Elizabeth Ann
ASCO Annual Meeting Proceedings
Safety and long-term maintenance of anti-HER2 immunity following booster inoculations of the E75 breast cancer vaccine.
Vreeland TJ, Hale DF, Sears AK, Clifton GT, Pappou E, Dabney RS, Ardavanis A, Patil R, Ponniah S, Anastasopoulou E, Perez SA, Papamichail M, Shumway NM, Peoples GE, Mittendorf EA.
ASCO Annual Meeting Proceedings
From bench to bedside: The use of the li-Key technology to improve helper peptides for clinical use in cancer vaccines.
Pugh TJ, Frank SJ, Achim M, Kuban DA, Lee AK, Hoffman KE, McGuire SE, Swanson DA, Kudchadker R, Davis JW
Brachytherapy
Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy
Hale, DF and Vreeland, TJ and Perez, SA and Berry, JS and Ardavanis, A and Trappey, AF and Tzonis, P and Sears, AK and Clifton, GT and Shumway, NM and others
Cancer Research
The combination of trastuzumab and HER2-directed peptide vaccines is safe in HER2-expressing breast cancer patients
Vreeland, Timothy J and Dabney, Raetasha S and Hale, Diane F and Sears, Alan K and Clifton, Guy T and Zacharia, Athina and Jama, Yusuf and Chiplis, Anna and Mursal, Mohamed and Shumway, Nathan M and others
Cancer Research
Immune reconstitution after chemotherapy correlates with increased in vitro immune response in breast cancer patients undergoing peptide vaccine therapy
Diane F. Hale, Timothy J. Vreeland, Raetasha S. Dabney, G Travis Clifton, Alan K. Sears, Efi Pappou, Eleftheria Anastasopoulou, Alexandros Ardavanis, Sathibalan Ponniah, Michael Papamichail, Sonia Perez, Nathan Shumway, George E. Peoples, Elizabeth Mittendorf
Cancer Research
Abstract LB-218: Immune response assessment in a phase II trial of AE37 HER2 peptide vaccine
JM Greene, EJ Schneble, S Perez, JL Murray, JS Berry, AF Trappey, DF Hale, TJ Vreeland, GT Clifton, A Ardavanis, JK Litton, NM Shumway, M Papamichail, GE Peoples, EA Mittendorf 
Cancer Research
Abstract P2-11-01: Final pre-specified analysis of the phase II trial of the GP2+ GM-CSF peptide vaccine in high risk breast cancer patients to prevent recurrence

Weinthal, Joel, M.D

Clinical Roundtable Monograph
Disease State Awareness in Gaucher Disease: A Q&A Expert Roundtable Discussion
Brow M, Okon T, George E, Eagle D, Patt D, Gould B, Brooks B, Cobb P, White C, Tetrault S, Beveridge R.
Community Oncology
Thoughts and recommendations on cancer care site of service

John Sandbach, M.D. 
Lucy Langer, M.D., M.S.H.S., Lisa Clark, F.N.P., A.O.C.N.P., Justin Gress, Debra Patt, M.D., Neelima Denduluri, M.D., Yunfei Wang, Ph.D., Jay Andersen, M.D., Magdolna Solti, M.D., Amanda Wheeler, M.D., Tammy Delamelena, M.D., John Smith II, M.D.

Compass Oncology
A Structured Genetic Risk Evaluation and Testing Program in the Community Oncology Practice Increases Identification of Individuals at Risk for BRCA Mutations

Download full publication here.

Tobenna Nwizu, Ravi Salgia
Emerging Cancer Therapeutics
Molecular Biology of Lung Cancer and Therapeutic Implications

R Lyons
S Verstovsek, R Mesa, J Gotlib, R Levy, V Gupta, J DiPersio, J Catalano, M Deininger, C Miller, R Silver, M Talpaz, E Winton, J Harvey, M Arcasoy, E Hexner, R Paquette, A Raza, K Vaddi, S Erickson-Viitanen, W Sun, V Sandor, H Kantarjian

European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes
Consistent Benefit of Ruxolitinib Over Placebo Across Myelofibrosis Patient Subgroups: Results From COMFORT-1

Download full publication here.

Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA
European Journal of Cancer
Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease?
Doshi G, Sonpavde G, Sternberg CN.
Expert Opinion on Drug Metabolism & Toxicology
Clinical and pharmacokinetic evaluation of satraplatin.
Hale, Diane F and Clifton, G Travis and Sears, Alan K and Vreeland, Timothy J and Shumway, Nathan and Peoples, George E and Mittendorf, Elizabeth A
Expert Review of Vaccines
Cancer vaccines: should we be targeting patients with less aggressive disease?
Dinkelspiel H, Fetterman B, Poitras N, Kinney WK, Cox JT, Lorey T, Castle PE
Gynecologic Oncology
Screening history preceding a diagnosis of cervical cancer in women age 65 and older

John F. Sandbach, M.D. 
Anne-Renee Hartman, M.D., Rajesh R. Kaldate, M.S., Lisa M. Sailer, M.S.N., Lisa Painter, M.S.N., Charles E. Grier, Ph.D., Robbin R. Endsley, M.S., Marlena Griffin, B.S., Stephanie A. Hamilton, B.A., Cynthia A. Frye, M.S., Mark A. Silberman, M.D. and Richard J.Wenstrup, M.D.

Hartman
Prevalence of BRCA Mutations in an Unselected Population of Triple-Negative Breast Cancer

Download full publication here.

Nwizu T, Cohen EE
Head & Neck Oncology Multidisciplinary Approach to Head & Neck Neoplasms
Chemotherapy & Targeted Therapy in Head & Neck Cancer
McGuire SE, Lee AK, Cerne JZ, Munsell MF, Levy LB, Kudchadker RJ, Choi SL, Nguyen QN, Hoffman KE, Pugh TJ, Frank SJ, Corn PG, Logothetis CJ, Kuban DA
International Journal of Radiation Oncology
PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose-escalated radiation therapy era
Quan EM, Li X, Li Y, Wang X, Kudchadker RJ, Johnson JL, Kuban DA, Lee AK, Zhang X
International Journal of Radiation Oncology
A Comprehensive Comparison of IMRT and VMAT Plan Quality for Prostate Cancer Treatment
Castle KO, Hoffman KE, Levy LB, Lee AK, Choi S, Nguyen QN, Frank SJ, Pugh TJ, McGuire SE, Kuban DA
International Journal of Radiation Oncology 
Is Androgen Deprivation Therapy Necessary in All Intermediate-Risk Prostate Cancer Patients Treated in the Dose Escalation Era?
Patt D, Espirito J, Turnwald B, Hoverman J, Neubauer M, Cartwright T, Busby L, Brooks B, Sitarik M, Kolodiej M, Beveridge R
JCO supplements
Changes in adjuvant breast cancer chemotherapy regimen selection over time in the community
Walker JG, Schultz D, Grisdale K, Groves MD
Journal of Advanced Practice in Oncology
Case Studies of Patients Receiving Intraventricular Topotecan for Treatment of Neoplastic Meningitis
Wootton L, Kudchadker R, Beddar A, Lee AK
Journal of Applied Clinical Medical Physics
Effectiveness of a novel gas-release endorectal balloon in the removal of rectal gas for prostate proton radiation therapy

Roger M. Lyons
Moshe Talpaz, Solomon I. Hamburg, Katarzyna Jamieson, Howard R. Terebelo, Lawrence Afrin, Elliott F. Winton, Michael A. Scola, Jimmie Huling Harvey, Chris E. Holmes, Gregory L. Ortega, Josef T. Prchal, Richard T. Silver, Maria R. Baer, Susan Kay Erickson-Viitanen, Peter O'Neill, Wei Peng, Lance Leopold, Hagop Kantarjian, Srdan Verstovsek

Journal of Clinical Oncology
Preliminary Safety and Efficacy of Ruxolitinib in Patients with Primary and Secondary Myelofibrosis with Platelet Counts of 50-100x10^9L

Download full publication here.

Roger M. Lyons
Srdan Verstovsek, Ruben A. Mesa, Jason R. Gotlib, Vikas Gupta, John F. DiPersio, John V. Catalano, Michael W.N. Deininger, Carole Brennan Miller, Richard T. Silver, Moshe Talpaz, Elliott F. Winton, Jimmie Huling Harvey, Murat O. Arcasoy, Elizabeth O. Hexner,Ronald Paquette, Azra Raza, William Sun, Hagop Kantarjian

Journal of Clinical Oncology
Adverse Events and the Return of Myelofibrosis-Related Symptoms After Treatment Interruption or Discontinuation in the Comfort-I Study

Download full publication here.

Krop I, Demuth T, Guthrie T, Wen P, Mason WP, Chinnaiyan P, Butowski N, Groves MD, Kesari S, Freedman SJ, Blackman S, Watters J, Loboda A, Podtelezhnikov A, Lunceford J, Chen C, Giannotti M, Hing J, Beckman R, LoRusso P
Journal of Clinical Oncology
Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients with Advanced Solid Tumors
Wang YZ, Diebold A, Woltering E, King H, Boudreaux JP, Anthony LB, Campeau R.
Journal of Gastrointestinal Surgery
Radioguided Exploration Facilitates Surgical Cytoreduction of Neuroendocrine Tumors.

Roger M. Lyons
Eunice S Wang, Roger M Lyons, Richard A Larson, Sunil Gandhi, Delong Liu, Carmen Matei, Bart Scott, Kuolung Hu, Allen S Yang

Journal of Hematology & Oncology
A Randomized, Double-blind, Placebo-controlled Phase 2 Study Evaluating the Efficacy and Safety of Romiplostim Treatment of Patients with Low or Intermediate-1 Risk Myelodysplastic Syndrome Receiving Lenalidomide

Download full publication here.

Roger M Lyons
Azra Raza1, Naomi Galili1, Deborah Mulford, Scott E Smith, Gail L Brown, David P Steensma, Ralph Boccia, Mikkael A Sekeres, Guillermo Garcia-Manero, Ruben A Mesa

Journal of Hematology & Oncology
Phase 1 Dose-ranging Study of Ezatiostat Hydrochloride in Combination with Lenalidomide in Patients with Non-deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Download full publication here.

Berry, JS and Vreeland, TJ and Trappey, AF and Hale, DF and Clifton, GT and Sears, AK and Patil, R and Shumway, NM and Holmes, JP and McCall, S and others
Journal of Immunotherapy
Trends in Circulating Tumor Cells (CTCS) in Multiple Adjuvant (ADJ) Trials of HER2-Specific Peptide Vaccines (PV) in Breast Cancer (BRCA) PTS
Archambault L, Poenisch F, Sahoo N, Robertson D, Lee A, Gillin MT, Mohan R, Beddar S
Medical Physics
Verification of proton range, position, and intensity in IMPT with a 3D liquid scintillator detector system
Cao W, Lim GJ, Lee A, Li Y, Liu W, Ronald Zhu X, Zhang X
Medical Physics
Uncertainty incorporated beam angle optimization for IMPT treatment planning

John Sandbach, M.D. 
Hartman AR, Kaldate RR, Sailer LM, Painter L, Grier CE, Endsley RR, Griffin M, Hamilton SA, Frye CA, Silberman MA, Wenstrup RJ.

Myriad Genetic Laboratories, Inc.
Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer.

Roger M Lyons
Srdan Verstovsek, M.D., Ph.D., Ruben A. Mesa, M.D., Jason Gotlib, M.D., Richard S. Levy, M.D., Vikas Gupta, M.D., John F. DiPersio, M.D., Ph.D., John V. Catalano, M.D., Michael Deininger, M.D., Ph.D., Carole Miller, M.D., Richard T. Silver, M.D., Moshe Talpaz, M.D., Elliott F. Winton, M.D., Jimmie H. Harvey, Jr., M.D., Murat O. Arcasoy, M.D., Elizabeth Hexner, M.D., Ronald Paquette, M.D., Azra Raza, M.D., Kris Vaddi, Ph.D., Susan Erickson-Viitanen, Ph.D., Iphigenia L. Koumenis, M.S., William Sun, Ph.D., Victor Sandor, M.D., and Hagop M. Kantarjian, M.D.

New England Journal of Medicine
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

Download full publication here.

Lewis MA, Jaramillo S, Roberts L, Fleming CJ, Rubin J, Grothey A.
Oncologist
Hepatic artery embolization for neuroendocrine tumors: postprocedural management and complications
Golden DW, Rudra S, Witt ME, Nwizu T, Cohen EE, Blair E, Stenson KM, Vokes EE, Haraf DJ
Oral Oncology
Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma
Russo R, Marks N, Morris K, King H, Gelvin A, Rooney R.
Orthopedics
Life-Threatening Necrotizing Fasciitis Due to Bath Salts Injection.
Rechner LA, Howell RM, Zhang R, Etzel C, Lee AK, Newhauser WD
Physics in Medicine and Biology
Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer
Dinkelspiel HE, Fetterman B, Kinney WK, Castle PE
Poster presentation at the American Society of Colposcopists and Cervical Pathologists Biennial Scientific Meeting
Sustained rise in the diagnosis of adenocarcinoma in situ in routine clinical practice.
Dinkelspiel HE, Fetterman B, Kinney WK, Poitras N, Lorey T, Castle PE
Poster presentation at the Society for Gynecologic Oncology 43rd Annual Meeting on Women’s Cancer
Screening history preceding and long-term risk of invasive cervical cancer following diagnosis of adenocarcinoma in situ in routine clinical practice.
Pugh TJ, Choi S, Nguyen QN, Gillin M, Zhu R, Palmer M, Lee AK
Practical Radiation Oncology
Proton beam therapy for the treatment of prostate cancer
Sharp H, Swanson D, Pugh TJ, Zhang M, Phan J, Kudchadker R, Bruno T, Kuban D, Lee AK, Choi S, Nguyen QN, Hoffman K, McGuire S, Frank S
Practical Radiation Oncology
Screening Colonoscopy Before Prostate Cancer Treatment Can Detect Colorectal Cancers in Asymptomatic Patients and Reduce the Rate of Complications After Brachytherapy
Klein D, Briere TM, Kudchadker R, Archambault L, Beaulieu L, Lee A, Beddar S
Radiation Measurements
In-phantom dose verification of prostate IMRT and VMAT deliveries using plastic scintillation detectors
Nwizu T, Ghi MG, Cohen EE, Paccagnella A.
Seminars in Radiation Oncology
The role of chemotherapy in locally advanced head and neck squamous cell carcinoma
King HM, Wang YZ.
Society of American Gastrointestinal and Endoscopic Surgeons Conference
Cocoon Formation in Patients with Mid-Gut Neuroendocrine Tumors – A Rare and Unrecognized Final Pathway.
Rezek Y, Gossner G, Wahl H, Tan L, Kueck A, Opipari A, Liu R
Society of Gynecologic Oncology Annual Meeting
Resveratrol Inhibits Glucose Uptake and Ovarian Cancer Growth In Vivo
Chawla, Vij et al.
Transplant Infectious Diseases
Oral Valganciclovir as Pre-emptive Therapy for CMV-Positive Patients After Allogeneic Hematopoietic Stem Cell Transplant: A Randomized Trial and Review of the Literature

Roger Lyons
Ruben Mesa, Jason Gotlib, Richard Levy, Vikas Gupta, John DiPersio, John Catalono, Michael Deininger, Carloe Miller, Richard Silver, Moshe Talpaz, Elliott Winton, Jimmie Harvey, Murat Arcasoy, Elizabeth Hexner, Roger Lyons, Ronald Paquette, Azra Raza, Kris, Vaddi, Sue Erikson-Viitanen, Iphegenia Koumenis, William Sun, Victor Sandor, Hagop Kantarjian

16th Congress of the European Hematology Association
Results of Comfort-1, A Randomized, Double-Blind Phase III Trial of the JAK1 and JAK2 Inhibitor Ruxolitinib (INCB018424) Versus Placebo for Patients with Myelofibrosis

Download full publication here.

Nwizu T, Ravi Salgia
Advances in Personalized Therapy for Lung Cancer
Biomarkers in lung cancer
Haney B, Shumway NM, Peoples GE
Advances in the Management of Triple Negative Breast Cancer
Advances in the Management of Triple Negative Breast Cancer Ch.9: Targeted therapies: other agents in clinical trials
Brown KM, Geller DA
Archives of Surgery
Porcelain Gallbladder and Risk of Gallbladder Cancer
Sears, AK and Clifton, GT and Patil, R and Shumway, NM and Carmichael, MG and Van Echo, DC and Holmes, JP and Ponniah, S and Mittendorf, EA and Peoples, GE
ASCO Annual Meeting Proceedings
Sequential administration of trastuzumab and a CD8 T-cell-eliciting HER2/neu peptide vaccine in patients with breast cancer compared to trastuzumab alone.
Clifton, GT and Sears, AK and Patil, R and Shumway, NM and Carmichael, MG and Van Echo, DC and Holmes, JP and McCall, S and Merrill, GA and Ponniah, S and others
ASCO Annual Meeting Proceedings
Monitoring of circulating tumor cell trends in a prospective, randomized, placebo-controlled HER2/neu peptide vaccine trial.

Roger M. Lyons
Srdan Verstovsek, MD, PhD, Ruben A. Mesa, MD, Jason Gotlib, MD, MS, Richard S. Levy, MD, Vikas Gupta, MD, FRCP, FRCPath, John F. DiPersio, MD, PhD, John Catalano, MD, Michael W. Deininger, Carole B. Miller, MD, Richard T. Silver, MD, Moshe Talpaz, MD, Elliott F. Winton, MD, Jimmie H. Harvey, Jr., MD, Murat O. Arcasoy, MD, Elizabeth Hexner, MD, Ronald Paquette, MD, PhD, Azra Raza, MD, Kris Vaddi, PhD, Sue Erickson-Viitanen, PhD, William Sun, PhD, Victor A. Sandor, MD, CM, Hagop M. Kantarjian

Blood
Clinical Burden and Progression of Myelofibrosis in a Controlled Study Population of Placebo-Treated Patients (COMFORT-1)

Download full publication here.

Roger M. Lyons
Azra Raza, MD, Naomi Galili, Ph.D., Deborah Mulford, MD, Scott E. Smith, MD, PhD, FACP, Gail Brown, MD, Lisa Meng, PhD, David P. Steensma, MD, Ralph Boccia, MD, Mikkael A. Sekeres, MD, MS, Guillermo Garcia-Manero, Ruben A. Mesa, MD

Blood
Phase I Dose-Ranging Study of Oral Ezatiostat Hydrochloride (Telintra, TLK199) in Combination with Lenalidomide (Revlimid) in Patients with Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Download full publication here.

Roger M. Lyons
Pierre Fenaux, MD, PhD, Hagop M. Kantarjian, Petra Muus, MD, PhD, Richard A. Larson, MD, Mikkael A. Sekeres, MD, MS, Pamela S. Becker, MD, PhD, Catherine Jia, PhD, Allen S. Yang, MD, PhD

Blood
Update of an Open-Label Extension Study Evaluating the Long-Term Safety & Efficacy of Romiplostim in Thrombocytopenic Patients with Myelodysplastic Syndromes (MDS)

Download full publication here.

Roger M. Lyons, MD
Srdan Verstovsek, MD, PhD, Ruben A. Mesa, MD, Jason Gotlib, MD, MS, Richard S. Levy, MD, Vikas Gupta, MD, FRCP, FRCPath, John F. DiPersio, MD, PhD, John Catalano, MD, Michael W. Deininger, Carole B. Miller, MD, Richard T. Silver, MD, Moshe Talpaz, MD, Elliott F. Winton, MD, Jimmie H. Harvey Jr., MD, Murat O. Arcasoy, MD, Elizabeth Hexner, MD, Ronald Paquette, MD, PhD, Azra Raza, MD, Kris Vaddi, PhD, Sue Erickson-Viitanen, PhD, William Sun, PhD, Victor A. Sandor, MD, CM, Hagop M. Kantarjian

Blood
Consistent Benefit of Ruxolitinib Over Placebo in Spleen Volume Reduction and Symptom Improvement Across Subgroups and Overall Survival Advantage: Results From COMFORT-1

Download full publication here.

Roger M. Lyons, MD
Jeffrey Wasser, MD, Ralph Vincent V. Boccia, MD, Romeo Mandanas, Ingrid Pabinger, Marc Michel IV, Jean-François Viallard, MD-PhD, Xuena Wang, PhD, Richard Lizambri, MD

Blood
Use of Rituximab in a Study Comparing the Thrombopoietin Mimetic Romiplostim with Standard of Care (SOC) in Patients with Immune Thrombocytopenia (ITP)

Download full publication here.

Roger M. Lyons, MD
Billie J. Marek1, Surabhi Sharma, Carole Paley, Jason Esposito, Lawrence Garbo, MD, NicholasnDiBella1, Guillermo Garcia-Manero

Blood
24-Month Analysis of the Impact of Chelation on Clinical Outcomes in 600 Patient Registry of Lower-Risk MDS Patients

Download full publication here.

Roger M. Lyons, MD
David J. Kuter, MD, DPhil, James B. Bussel, MD, Adrian Newland, FRCP, Jeffrey S. Wasser, MD, James N. George, MD, Gail Macik, MD, Kun Nie, Susie Jun

Blood
Long-Term Efficacy and Safety of Romiplostim Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP): Final Report from an Open-Label Extension Study

Download full publication here.

Giglio P, Dhamne M, Hess KR, Gilbert MR, Groves MD, Levin VA, Kang SL, Ictech SE, Liu V, Colman H, Conrad CA, Loghin M, de Groot J, Yung WK, Puduvalli VK.
Cancer
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma
Silva IA, Bai S, McLean K, Yang K, Griffith K, Thomas D, Ginestier C, Johnston C, Kueck A, Reynolds RK, Wicha MS, Buckanovich RJ
Cancer Research
Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells that Portens Poor Patient Survival
Reungwetwattana, T, Jaramillo, S, Molina, JR.
Clinical Medicine Insights: Therapeutics
Current and Emerging Therapies in Peripheral T-cell Lymphoma: Focus on Pralatrexate
Brewer M, Kueck A, Runowicz CD
Clinical Obstetrics and Gynecology
Chemotherapy in Pregnancy
Nwizu T, Kanteti R, Rolle C, Vokes E, Salgia R
Drugs of the Future
Crizotinib (PF02341066) as a ALK/MET inhibitor- Special Emphasis as a Therapeutic Drug Against Lung Cancer
Sears, Alan K and Perez, Sonia A and Clifton, Guy T and Benavides, Linda C and Gates, Jeremy D and Clive, Kevin S and Holmes, Jarrod P and Shumway, Nathan M and Van Echo, David C and Carmichael, Mark G and others
Expert Opinion on Biological Therapy
AE37: a novel T-cell-eliciting vaccine for breast cancer
Dinkelspiel HE, Poitras N, Fetterman B, Kinney WK, Cox  T, Lorey T, Castle PE
Featured Poster presentation at the Society for Gynecologic Oncology 42nd Annual Meeting on Women’s Cancer
Pap negative HPV positive screening results: compliance with follow-up and results of follow-up.
Preibe A, Tan L, Wahl H, Kueck A, He G, Kwok R, Opipari A, Liu JR
Gynecologic Oncology
Glucose Deprivation Activates AMPK and Induces Cell Death through Modulation of Akt in Ovarian Cancer Cells
Kuban DA, Levy LB, Cheung MR, Lee AK, Choi S, Frank S, Pollack A
International Journal of Radiation Oncology
Long-term Failure Patterns and Survival in a Randomized Dose-Escalation Trial for Prostate Cancer. Who Dies of Disease? 
Zhu XR, Poenisch F, Song X, Johnson JL, Ciangaru G, Taylor MB, Lii M, Martin C, Arjomandy B, Lee AK, Choi S, Nguyen QN, Gillin MT, Sahoo N
International Journal of Radiation Oncology
Patient-Specific Quality Assurance for Prostate Cancer Patients Receiving Spot Scanning Proton Therapy Using Single-Field Uniform Dose
Park PC, Zhu XR, Lee AK, Sahoo N, Melancon AD, Zhang L, Dong L
International Journal of Radiation Oncology
A Beam-specific Planning Target Volume (PTV) Design for Proton Therapy to Account for Setup and Range Uncertainties

Roger M Lyons
Craig Reynolds, Nicholas Di Bella, William Hyman, Donald A. Richards, Gerald J. Robbins, Mark Vellek, Kristi A. Boehm, Feng Zhan & Lina Asmar

Investigational New Drugs
A Phase III Trial of Fludarabine, Cyclophosphamide, and Rituximab vs. Pentostatin, Cyclophosphamide, and Rituximab in B-Cell Chronic Lymphocytic Leukemia

Download full publication here.

Patt D, Espirito J, Turnwald B, Hoverman J, Neubauer M, Busby L, Brooks, Kolodziej, Anderson R, Beveridge R
JCO Supplements
Utilization of pegfilgrastim in adjuvant chemotherapy regimens for breast cancer in the community
Chen C, Patt D, Kazzaz D, Shankleton J, Forsyth M, Ganesh R
JCO Supplements
Evaluating utilization characteristics for the Oncotype DX recurrence score in early-stage breast cancer
Ginsburg A, Patt D, Flinn J, Espirito J, Neubauer M, Cartwright T, Hoverman J, Busby B, Brooks, B Kolodziej M, Sitarik M, Anderson R, Beveridge R
JCO Supplements
Understanding male breast cancer in the community setting
Patt D, Espirito J, Turnwald B, Hoverman J, Neubauer M, Cartwright T, Brooks B, Busby L, Sitarik M, Kolodziej M, Ginsburg A, Sheth S, Garey J, Clayton M, Nelson R, Anderson R, Beveridge R
JCO Supplements
Utilization and relative value of breast cancer adjuvant chemotherapy regimens in the community
Heng L, Lee AK, Johnson J, Zhu R, Kudchadker R
Journal of Applied Clinical Medical Physics
Characterization of dose impact on IMRT and VMAT from couch attenuation for two Varian couches
Choi S, Lee AK
Journal of Drug, Healthcare and Patient Safety
Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer

Roger M. Lyons
Sharon T Wilks, Shelby Young, Gail L Brown

Journal of Hematology & Oncology
Oral Ezatiostat HCl (Telintra, TLK199) and Idiopathic Chronic Neutropenia (ICN): A Case Report of Complete Response of a Patient with G-CSF Resistant ICN Following Treatment with Ezatiostat, a Glutathionie S-transferase P1-1 (GSTP1-1) Inhibitor

Download full publication here.

Kolodziej M, Hoverman JR, Garey JS, Espirito J, Sheth S, Ginsburg A, Neubauer MA, Patt D, Brooks B, White C, Sitarik M, Anderson R, Beveridge R
Journal of Oncology Practice
Benchmarks for value in cancer care: an analysis of a large commercial population
Hoverman, JR. Cartwright TH. Patt, DA. Espirito, JL. Clayton, MP. Garey, JS. Kopp, TJ. Kolodziej, M. Neubauer, M. Fitch, K. Pyenson, B. Beveridge, RA
Journal of Oncology Practice
Pathways, Outcomes, and Costs in Colon Cancer:  Retrospective evaluations in two distinct databases

Roger M Lyons
David Claxton, Harry P. Erba, Stefan Faderl, Martha Arellano, Tibor Kovacsovics, Janice Gabrilove, Dirk Huebner, Pritesh J. Gandhi, Hagop Kantarjian

Leukemia and Lymphoma
Outpatient Consolidation Treatment with Clofarabine in a Phase 2 Study of Older Adult Patients with Previously Untreated Acute Myelogenous Leukemia (AML)

Download full publication here.

R.M. Lyons
P. Fenaux, H. Kantarjian, R.A. Larson, M.A. Sekeres, P.S. Becker, P. Muus, C. Jia, A.S. Yang

Leukemia Research
Update of an Open-Label Extension Study Evaluating the Long-Term Safety & Efficacy of Romiplostim in Thrombocytopenic Patients with Myelodysplastic Syndromes

Download full publication here.

R.M. Lyons
G. Garcia-Manero, B.J. Marek, N. Martinez-Lopez, J. Esposito, C. Paley, N. DiBella

Leukemia Research
A 12-Month Follow-Up of an Ongoing Prospective, Non-Interventional, Multicenter Registry in Iron Overloaded Patients with Lower-Risk Myelodysplastic Syndromes

Download full publication here.

O’Shaughnessy, J. Osborne, C. Pippen, JE. Yoffee, M. Patt, D. Rocha C. Koo, IC. Sherman BM. Bradley, C.
New England Journal of Medicine
Iniparib plus Chemotherapy n Metastatic Triple-Negative Breast Cancer
King HM, Wang YZ
North American Neuroendocrine Tumor Society Conference
Cocoon Formation in Patients with Mid-Gut Neuroendocrine Tumors – A Rare and Unrecognized Final Pathway.
Dinkelspiel HE, Kinney WK, Poitras N, Fetterman B, Cox JT, Lorey T, Castle PE
Oral Plenary presentation at the Society for Gynecologic Oncology 42nd Annual Meeting on Women’s Cancer
Cervical cancer rates in clinical practice with cotesting and interval extension.
Dinkelspiel HE, Fetterman B, Poitras N, Kinney WK, Cox JT, Lorey T, Castle PE
Oral presentation at Eurogin Conference
Screening history preceding a diagnosis of cervical cancer in women age 65 and older. 
Kinney WK, Dinkelspiel HE, Fetterman B, Castle PE
Oral presentation at Eurogin Conference
Risk of invasive cancer in routine clinical practice following a CIN2 or CIN2/3 biopsy.
Dinkelspiel HE, Poitras N, Fetterman B, Lorey T, Kinney WK
Oral presentation at the Western Association of Gynecologic Oncologists 40th Annual Meeting
Lessons from practice: cervical cancer antecedents in the cotesting era.
Vassiliev ON, Kudchadker RJ, Kuban DA, Frank SJ, Choi S, Nguyen Q, Lee AK
Physica Medica
Dosimetric impact of fiducial markers in patients undergoing photon beam radiation therapy
Dinkelspiel HE, Flanagan T, Kinney WK, Fetterman B, Lorey T, Castle PE
Poster presentation at the Society for Gynecologic Oncology 42nd Annual Meeting on Women’s Cancer, Orlando
Consequences of lengthening cervical cancer screening intervals on mammography rates.
Joseph S, Moore BT, Sorensen GB, Earley JW, Tang FM, Jones PG, Brown KM
Surgical Endoscopy
Single Incision Laparoscopic Cholecystectomy: a Comparison with the Gold Standard
McNally ME, Moore BT, Brown KM
Surgical Endoscopy
Single-incision Laparoscopic Colectomy for Malignant Disease
Hoverman JR, Cartwright TH, Patt DA, Espirito JL, Clayton MP, Garey JS, Kopp TJ, Kolodziej M, Neubauer MA, Fitch K, Pyenson B, Beveridge RA
The American Journal of Managed Care
Pathways, Outcomes, and Costs in Colon Cancer: Retrospective Evaluations in 2 Distinct Databases
Pugh TJ, Lee AK
Urologic Clinics of North America
Role of radiation therapy for the treatment of lymph nodes in urologic malignancies
Frank SJ, Kudchadker RJ, Kuban DA, De Crevoisier R, Lee AK, Cheung RM, Choi S, Tucker SL, Dong L
American Journal of Clinical Oncology
A volumetric trend analysis of the prostate and seminal vesicles during a course of intensity-modulated radiation therapy
Iyengar P, Levy LB, Choi S, Lee AK, Kuban DA
American Journal of Clinical Oncology
Toxicity Associated With Postoperative Radiation Therapy for Prostate Cancer
American Journal of Obstetrics and Gynecology
Inhibition of Glycolysis Enhances Cisplatin-induced Apoptosis in Ovarian Cancer Cells
*Groves MD*
Archives of neurology
New Strategies in the Management of Leptomeningeal Metastases

Roger M. Lyons
Nicholas Di Bella, Raymond Taetle, Kathryn Kolibaba, Thomas Boyd, Robert Raju, David Barrera, Ernest W. Cochran Jr, Philip Y. Dien, Peter J. Schlegel, Svetislava J. Vukelja, Julie Boston, Kristi A. Boehm, Yunfei Wang, Lina Asmar

Blood
Results of a Phase II Study of Bortezomib in Patients with Relapsed or Refractory Indolent Lymphoma

Download full publication here.

Roger M. Lyons, MD
Pierre Fenaux, MD, PhD, Hagop Kantarjian, MD, Richard A Larson, MD, Mikkael A Sekeres, MD, MS, Pamela Becker, MD, PhD, Petra Muus, MD, PhD, Catherine Jia, PhD,8 Allen S Yang, MD, PhD

 

Blood
Update from an Open-Label Extension Study Evaluating the Long-Term Safety and Efficacy of Romiplostim in Thrombocytopenic Patients with Myelodysplastic Syndromes

Download full publication here.

Sandbach J
Eisenbraun A, Wenstrup R, Fry C, Reid, J, Hellerstedt, B, and Sailer, L

Community Oncology
Hereditary Breast and Ovarian Cancer Testing Integration and Outcomes within Community Oncology Practices.
Nwizu T, Stadler W
Directed Therapies
Pharmacodynamic and Predictive Biomarkers for VEGF and mTOR
Archambault L, Briere TM, Pönisch F, Beaulieu L, Kuban DA, Lee A, Beddar S
International Journal of Radiation Oncology
Toward a real-time in vivo dosimetry system using plastic scintillation detectors
Meyer J, Bluett J, Amos R, Levy L, Choi S, Nguyen QN, Zhu XR, Gillin M, Lee A
International Journal of Radiation Oncology
Spot Scanning Proton Beam Therapy for Prostate Cancer: Treatment Planning Technique and Analysis of Consequences of Rotational and Translational Alignment Errors
Tucker SL, Dong L, Bosch WR, Michalski J, Winter K, Mohan R, Purdy JA, Kuban D, Lee AK, Cheung MR, Thames HD, Cox JD
International Journal of Radiation Oncology
Late Rectal Toxicity on RTOG 94-06: Analysis Using a Mixture Lyman Model
Herman MP, Wernicke GA, Yan W, Nori D, Parashar B.
Journal of Cancer Research and Therapeutics
Pure seminoma in the setting of androgen insensitivity syndrome treated with surgical resection and para-aortic radiation: a case report and review of literature.

Roger M. Lyons
Hagop Kantarjian, Pierre Fenaux, Mikkael A. Sekeres, Pamela S. Becker, Adam Boruchov, David Bowen, Eva Hellstrom-Lindberg, Richard A. Larson, Petra Muus, Jamile Shammo, Robert Siegel, Kuolung Hu, Janet Franklin, Dietmar P. Berger

Journal of Clinical Oncology
Safety and Efficacy of Romiplostim in Patient with Lower-risk Myelodysplastic Syndrome (MDS) and Thrombocytopenia

Download full publication here.

Roger M. Lyons
Hagop M. Kantarjian, Harry P. Erba, David Claxton, Martha Arellano, Tibor Kovascovics, Janice Gabrilove, Michael Craig, Dan Douer, Michael Maris, Stephen Petersdorf, Paul J. Shami, Andrew M. Yeager, Stephen Eckert, Rekha Abichandani, and Stefan Faderl

Journal of Clinical Oncology
Phase II Study of Clofarabine Monotherapy in Previously Untreated Older Adults with Acute Myeloid Leukemia and Unfavorable Prognostic Factors

Download full publication here.

Sandbach J
Loesch D, Greco FA, Senzer NN, Burris HA, Hainsworth JD, Jones S, Vukelja SJ, Holmes F, Sedlacek S, Pippen J, Lindquist D, McIntyre K, Blum JL, Modiano MR, Boehm KA, Zhan F, Asmar L, Robert N.

Journal of Clinical Oncology
Phase III Multicenter Trial of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel Compared With Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel As Adjuvant Therapy for Women With High-Risk Breast Cancer.
Neubauer, MA. Espirito, JL, Clayton, M. Patt, DA.
Journal of Clinical Oncology
Combination versus sequential chemotherapy for metastatic breast cancer: An evaluation of outcomes from a community oncology network
Grills IS, Mangona VS, Welsh R, Chmielewski G, Mcinerney E, Martin S, et al.
Journal of Clinical Oncology
Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.
Grisdale K, Ritterhouse M, Hunter K, Williams MD, Groves MD
Journal of Neuro-Oncology
Tonsillar Pseudotumor: Complications of Chronically-administered Temozolomide
Walbert T, Gilbert MR, Groves MD, Puduvalli VK, Alfred Yung WK, Conrad CA, Bobustuc GC, Colman H, Hsu SH, Nebiyou Bekele B, Qiao W, Levin VA
Journal of Neuro-Oncology
Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma
Gehring K, Patwardhan SY, Collins R, Groves MD, Etzel CJ, Meyers CA, Wefel JS
Journal of Neuro-Oncology
A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor

Barrera, David N. D.O. 
Nicholas Di Bella, Raymond Taetle, Kathryn Kolibaba, Thomas Boyd, Robert Raju, David Barrera, Ernest W. Cochran, Jr, Philip Y. Dien, Roger Lyons, Peter J. Schlegel, Svetislava J. Vukelja, Julie Boston, Kristi A. Boehm, Yunfei Wang, and Lina Asmar 

Journal of the American Society of Hematology
Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphoma
Lee AK, Amling CL
Journal of the National Comprehensive Cancer Network
Appropriate use of nomograms to guide prostate cancer treatment selection
Socinski, MA. Raju, RN. Stinchombe, T. Kocs, DM. Couch, LS.Barrera, D. Rousey, SR. Choksi, JK. Jotte, R. Patt, DA. Periman, PO. Schlossberg, HR. Weissman, CH. Wang, Y. Asmar, L. Pritchard, S. Bromund J. Peng, G. Treat, J. Obasaju, CK.
Journal of Thoracic Oncology
Randomized phase II trial of pemetrexed and carboplatin with or without enzastaurin versus docetaxel and carboplatin as first-line treatment of patients with stage IIIB/IV non-small cell lung cancer
Journal of Thoracic Oncology
Phase I/II Study if AT-101 with Topoteran in Relapsed and Refractory Small Cell Lung Cancer
Zhu XR, Sahoo N, Zhang X, Robertson D, Li H, Choi S, Lee AK, Gillin MT
Medical Physics
Intensity modulated proton therapy treatment planning using single-field optimization: the impact of monitor unit constraints on plan quality
Gilbert MR, Gonzalez J, Hunter K, Hess K, Giglio P, Chang E, Puduvalli V, Groves MD, Colman H, Conrad C, Levin V, Woo S, Mahajan A, de Groot J, Yung WK
Neuro-Oncology
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma
Scholl, P. Snyder, N. Patt, D. Talbott, B
Otolaryngology-Head and Neck Surgery
Pilomatrical carcinosarcoma
Cheung J, Kudchadker RJ, Zhu XR, Lee AK, Newhauser WD
Physics in Medicine and Biology
Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancer
Patt, D, Espirito, J, Turnwald, B, Hoang, S, Hoverman, J.
Proceedings ASCO Breast Cancer Symposium
Ixabepilone alone and in combination with chemotherapy in the community setting
Chawla & Ellis
Surgical Oncology Clinics of North America
A Review of Neoadjuvant Endocrine Therapy for Breast Cancer 
Shumway, NM and Terrazzino, SE and Jones, CB
ASCO Annual Meeting Proceedings
A randomized pilot study comparing aprepitant to olanzapine for treatment of chemotherapy-induced nausea and vomiting
Shumway, Nathan M and Ibrahim, Nuhad and Ponniah, Sathibalan and Peoples, George E and Murray, James L
BioDrugs
Therapeutic Breast Cancer Vaccines

Roger M. Lyons
James B. Bussel, David J. Kuter, Vinod Pullarkat, Matthew Guo, Janet L. Nichol

Blood
Safety and Efficacy of Long-Term Treatment with Romiplostim in Thrombocytopenic Patients with ITP

Download full publication here.

Roger M. Lyons, MD
Guillermo Garcia-Manero, Billie J. Marek, Noelia Martinez-Lopez, Carole Paley, Peter L. Greenberg

Blood
Clinical Parameters in 391 Iron-Overloaded Patients with Lower-Risk MDS Enrolled in a Prospective, Non-Interventional Multicenter Registry

Download full publication here.

Roger M. Lyons
Stefan Faderl, MD, Harry P Erba, David F. Claxton, M.D., M. Arellano, Tibor J. Kovacsovics, MD, Janice Gabrilove, MD, Elizabeth Anderson, Elly Barry, MD, Hagop M. Kantarjian, MD

Blood
Outpatient Treatment with Clofarabine in Phase II Study of Older Adult Patients with Previously Untreated Acute Myelogenous Leukemia

Download full publication here.

Roger M. Lyons
Stefan Fader, MD, Harry P Erba, David F. Claxton, M.D, M. Arellano,  Tibor J. Kovacsovics, MD, Janice Gabrilove, MD, Elizabeth Anderson, Elly Barry, MD, Hagop M. Kantarjian, MD

Blood
Clorfarabine Produces Durable Remissions in Older Patients with AML with Unfavorable Prognostic Factors and Multiple Comorbidities

Download full publication here.

Roger M. Lyons
Harry P Erba, Stefan Fader, MD, David F. Claxton, MD, M. Arellano, Tibor J. Kovacsovics, MD, Janice Gabrilove, MD, Stephen Eckert, Ph.D, Dirk Huebner, MD, Hagop M. Kantarjian, MD

Blood
Single-Agent Clofarabine Produces Durable Remissions in Patients with Acute Myelogenous Leukemia (AML) Who > or = 70, Have Intermediate or Unfavorable Cytogenetics, Antecedent Hematological Disorders (AHD), or 2 or More Unfavorable Prognostic Factors

Download full publication here.

Roger M Lyons
Richard A. Larson, MD, Michael A. Kosmo, MD, Sunil Gandhi, Delong Liu, MD, PhD, Marc Chernoff, Luke Dreisbach, MD, Carmen Matei, Kuolong Hu, Ph, Janet L. Franklin, MD, MPH, Dietmar Berger, MD, PhD

Blood
Randomized Phase II Study Evaluating the Efficacy and Safety of Romiplostim Treatment of Patients with Low or Intermediate Risk Myelodysplastic Syndrome (MDS) Receiving Lenalidomide

Download full publication here.

Roger M Lyons
Janice Gabrilove, MD, Stefan Fader, MD, Harry P Erba, David F. Claxton, M.D., M. Arellano, Tibor J. Kovacsovics, MD, Stephen Eckert, Ph.D, Dirk Huebner, MD, Hagop M. Kantarjian, MD

Blood
Complete Response to Clofarabine Is Durable and Correlates with Survival in Previously Untreated Older Adults with Acute Myeloid Leukemia (AML) and Unfavorable Prognostic Factors

Download full publication here.

Roger M Lyons
Pierre Fenaux, Hagop Kantarjian, MD, Richard A. Larson, MD, Mikkael A. Sekeres, MD, MS, Pamela S. Becker, MD, PhD, Petra Muus, MD, PhD, Kuolong Hu, PhD, Dietmar Berger, MD, PhD, Janet L. Franklin, MD, MPH

Blood
An Open-Label Extension Study Evaluating the Long-Term Safety and Efficacy of Romiplostim in Thrombocytopenic Patients with Myelodysplastic Syndromes (MDS)

Download full publication here.

Roger M Lyons
Ralph V. Boccia, MD, Gail Macik, MD, Romeo A. Mandanas, MD, FACP, Xuena Wang, Richard Lizambri, MD,d Dietmar Berger, MD, PhD

Blood
Home Administration of Romiplostim by Patients with Chronic Immune Thrombocytopenia (ITP)

Download full publication here.

Groves MD, Puduvalli VK, Gilbert MR, Levin VA, Conrad CA, Liu VH, Hunter K, Meyers C, Hess KR, Alfred Yung WK
British Journal of Cancer
Two Phase II Trials of Temozolomide with Interferon-a2b (Pegylated and non-pegylated) in Patients with Recurrent Glioblastoma Multiforme

Roger M. Lyons
JN George, SD Mathias, RS Go RS, M Guo, DH Henry, RL Redner, L Rice, MR Schipperus

British Journal of Haematology
Improved Quality of Life for Romiplostim-Treated Patients with Chronic Immune Thormbocytopenic Purpura: Results from Two Randomized, Placebo-Controlled Trials

Roger M. Lyons, M.D., F.A.C.P.
Jamile M. Shammo, M.D., F.A.S.C.P., Lewis R. Silverman, M.D., Bart L. Scott, M.D.

Clinical Advances in Hematology & Oncology
Treatment Selection for Myelodysplastic Syndrome Patients in a Community Setting 

Download full publication here.

Current Surgical Diagnosis and Treatment, 13th ed.
Gynecology
Rhode J, Kueck A, Haefner H
Female Sexual Pain Disorders: Evaluation and Management
Hidradenitis Suppurativa
Fontenot JD, Lee AK, Newhauser WD
International Journal of Radiation Oncology
Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer
Kudchadker RJ, Lee AK, Yu ZH, Johnson JL, Zhang L, Zhang Y, Amos RA, Nakanishi H, Ochiai A, Dong L
International Journal of Radiation Oncology
Effectiveness of Using Fewer Implanted Fiducial Markers for Prostate Target Alignment
Herman MP, Kopetz S, Bhosale PR, Eng C, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Delclos ME, Krishnan S, Crane CH, Das P.
International Journal of Radiation Oncology * Biology * Physics
Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical course

Roger M. Lyons
Thomas M. Cosgriff, Sanjiv S. Modi, Robert H. Gersh, John D. Hainsworth, Allen L. Cohn, Heidi J. McIntyre, Indra J. Fernando, Jay T. Backstrom, C.L. Beach

Journal of Clinical Oncology
Hematologic Response to Three Alternative Dosing Schedules of Azacitidine in Patients with Myelodysplastic Syndromes

Download full publication here.

R. M. Lyons
H. P. Erba, H. M. Kantarjian, D. F. Claxton, M. Arellano, T. J. Kovacsovics, J., Gabrilove, S. Eckert, S. Faderl

Journal of Clinical Oncology
Updated Remission Duration and Survival Results of Single-agent Clofarabine in Previously Untreated Older Adult Patients with Acute Myelogenous Leukemia Unlikely to Benefit From Standard Induction Chemotherapy Due to Unfavorable Baseline Risk Factor(s)

Download full publication here.

Groves MD, Hess KR, Puduvalli VK, Colman H, Conrad CA, Gilbert MR, Weinberg J, Cristofanilli M, Yung WK, Liu TJ.
Journal of Neuro-Oncology
Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma
Pulaski HL, Spahlinger G, Silva IA, McLean K, Kueck AS, Reynolds RK, Coukos G, Conejo-Garcia JR, Buckanovich RJ
Journal of Translational Medicine
Identifying Alemtuzumab as an Anti-myeloid Cell Antiangiogenic Therapy for the Treatment of Ovarian Cancer
Frank SJ, Levy LB, Kuban DA, Lee AK, Kudchadker RJ, Bruno TL, van Vulpen M, Swanson DA
Journal of Urology
Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapy
Smith A, Gillin M, Bues M, Zhu XR, Suzuki K, Mohan R, Woo S, Lee A, Komaki R, Cox J, Hiramoto K, Akiyama H, Ishida T, Sasaki T, Matsuda K
Medical Physics
The MD Anderson Proton Therapy System
Suki D, Hatiboglu MA, Patel AJ, Weinberg JS, Groves MD, Mahajan A, Sawaya R
Neurosurgery
Comparative Risk of Leptomeningeal Dissemination of Cancer after Surgery or Stereotactic Radiosurgery for Supratentorial Solid Tumor Metastases
Arjomandy B, Sahoo N, Cox J, Lee A, Gillin M
Physics in Medicine and Biology
Comparison of surface doses from spot scanning and passively scattered proton therapy beams
Chamberlain MC, Glantz M, Groves MD, Wilson WH
Seminars in Oncology
Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment
Brown KM
Surgical Clinics of North America
Multi-disciplinary Approach to Tumors of the Pancreas and Biliary Tree
Anderson JF, Swanson DA, Levy LB, Kuban DA, Lee AK, Kudchadker R, Phan J, Bruno T, Frank SJ
Urology
Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience
Courtney Sheinbein M.D., Bin S. Teh M.D., Wei Y. Mai M.D., Walter Grant Ph.D., Hsin Lu M.D., Arnold Paulino M.D., and E. Brian Butler M.D.
Urology
PSA Bounce After Intensity-Modulated Radiotherapy (IMRT) for Prostate Cancer
Chawla, Jane S.
Washington University in St. Louis
In Pursuit of Personalized Therapy for Breast Cancer: Gene Expression Signatures
Chawla, Jane S.
Washington University in St. Louis
A Phase II Study of Gemcitabine and a Multi-kinase Inhibitor in Metastatic Pancreatic Cancer
Chawla, Jane S.
Washington University in St. Louis
Neoadjuvant Chemotherapy for Rectal Cancer
Zhao, Sperry (Chawla), & Freeman et al.
Cancer Research
Inhibition of STAT3Tyr705 Phosphorylation by Smad4 Suppresses Transforming Growth Factor B–Mediated Invasion and Metastasis in Pancreatic Cancer Cells 

Hoverman, J. Russell M.D. 
Radebaugh, K.A.

American Society Clinical Oncology
Imaging in Early Breast Cancer

McCollum, David M.D. 
Richards D, Wilfong L, Sborov M, Boehm KA, Zhan F, and Asmar L.

Annals of Oncology
Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction.

Roger M. Lyons, MD
Nicholas Di Bella, MD, Raymond Taetle, MD, Kathryn S. Kolibaba, MD, Thomas E Boyd, MD, Robert N Raju, MD, David N Barrera, DO, Ernest Cochran, MD, Philip Dien, MD, David Hakimian, MD, Peter J Schlegel, MD, Svetislava J Vukelja, MD, Julie Boston, RN, Kristi A Boehm, MS, Yunfei Wang, MS, Lina Asmar, PhD

Blood
Results of a Phase II Study of Bortezomib in Patients with Relapsed or refractory Indolent Lymphoma

Download full publication here.

Roger M. Lyons, MD
Craig Reynolds, MD, Nicholas Di Bella, MD, William J Hyman, MD, Gary L. Lee, MD, Donald A Richards, MD, PhD, Gerald J. Robbins, MD, Mark Vellek, MD, Kristi A Boehm, MS, Feng Zhan, PhD, Lina Asmar, PhD

Blood
Phase III Trial of Fludarabine, Cyclophosphamide, and Rituximab Vs. Pentostatin, Cyclophosphamide, and Rituximab in B-Cell Chronic Lymphocytic Leukemia

Download full publication here.

Roger M. Lyons, MD
Harry Paul Erba, MD, PhD, Hagop Kantarjian, David F. Claxton, MD, M. Arellano4, Tibor J. Kovacsovics, MD, Janice Gabrilove, MD, Stephen Eckert, Ph.D, Rekha Abichandani, MD, Stefan Faderl, MD

Blood
Phase II Study of Single Agent Clofarabine in Previously Untreated Older Adult Patients with Acute Myelogenous Leukemia (AML) Unlikely to Benefit from Standard Induction Chemotherapy

Download full publication here.

Roger M. Lyons, MD
James George, MD, James B Bussel, MD, Vinod Pullarkat, MD, Robert Redner, MD, Deirdra Terrell, PhD, Kun Nie, PhD, Dietmar Berger, MD, PhD

Blood
Self-Injection of Romiplostim by Patients with Chronic Immune Thrombocytopenic Purpura (ITP)

Download full publication here.

Roger M. Lyons, MD
James B. Bussel, David J. Kuter, Vinod Pullarkat, Matthew Guo, Janet L. Nichol

Blood
Safety and Efficacy of Long-Term Treatment with Romiplostim in Thrombocytopenic Patients with ITP

Download full publication here.

Esler, William Vance, M.D. 
Lim, S.H., Periman, P.O., Beggs, D., Zhang, Y., and Townsend, M.

British Journal of Haematology
R-CHOP followed by consolidative autologous stem cell transplant and low dose rituxan maintenance therapy for advanced mantle cell lymphoma

Lim, S.H. M.D. 
Zhang, Y., Burris, C. and Townsend, M.

Bone Marrow Transplant

Successful salvage with unrelated umbilical cord blood transplant for Hodgkin’s disease relapsed following autologous stem cell transplant.

Roger M. Lyons
Janice Gabrilove, Ronald Paquette, Chaudhry Mushtaq, Mikkael A. Sekeres, Dianne Tomita, Lyndah Dreiling

British Journal of Haematology
Phase 2, Single-arm, Trial to Evaluate the Effectiveness of Darbopoetin alfa for Correcting Anaemia in Patients with Myelodysplastic Syndromes

Download full publication here.

Roger M. Lyons, MD, FACP
Richard Stone, MD, Mikkael Sekeres, MD, MS, Guillermo Garcia-Manero, MD

Clinical Advances in Hematology & Oncology
Recent Advances in Low- and Intermediate-1--Risk Myelodysplastic Syndrome: Developing a Consensus for Optimal Therapy

Download full publication here.

Hutson, Thomas E. D.O., PharmD, FACP
MD Galsky.

Expert Review of Anticancer Therapy
Current optimal chemotherapy for advanced urothelial cancer.
Quiros RM, Valianou M, Kwon Y, Brown KM, Godwin AK, Cukierman E
Gynecologic Oncology
Ovarian Normal and Tumor-associated Fibroblasts Retain In Vivo Stromal Characteristics in a 3-D Matrix-Dependent Manner

R Lyons
T. Cosgriff, S. Modi, H. McIntyre, I. Fernando, J. Backstrom, C.L. Beach

Haematologica
Rapid Onset of Effectiveness with Three Alternative Azacitidine (AZA) Dosing Regimens in Patients with Myelodysplastic Syndromes (MDS)

Download full publication here.

Kuban DA, Tucker SL, Dong L, Starkschall G, Huang EH, Cheung MR, Lee AK, Pollack A
International Journal of Radiation Oncology
Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer
O'Daniel JC, Dong L, Zhang L, Wang H, Tucker SL, Kudchadker RJ, Lee AK, Cheung R, Cox JD, Kuban DA, Mohan R
International Journal of Radiation Oncology
Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy
Frank SJ, Dong L, Kudchadker RJ, De Crevoisier R, Lee AK, Cheung R, Choi S, O'Daniel J, Tucker SL, Wang H, Kuban DA
International Journal of Radiation Oncology
Quantification of prostate and seminal vesicle interfraction variation during IMRT
Kudchadker RJ, Swanson DA, Kuban DA, Lee AK, Bruno TL, Frank SJ
International Journal of Radiation Oncology
Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era?
Sejpal SV, Amos RA, Bluett JB, Levy LB, Kudchadker RJ, Johnson J, Choi S, Lee AK
International Journal of Radiation Oncology
Dosimetric Changes Resulting From Patient Rotational Setup Errors in Proton Therapy Prostate Plans

R. Lyons
H. P. Erba, H. M. Kantarjian, D. Claxton, M. Arellano, T. Kovacsovics, J. Gabrilove, S. Eckert, R. Abichandani, S. Faderl

Journal of Clinical Oncology
Phase II Study of Single Agent Clofarabine in Previously Untreated Older Adult Patients with Acute Myelogenous leukemia (AML) Unlikely to Benefit from Standard Induction Chemotherapy

Download full publication here.

Groves MD, Katz RL
Journal of Neuro-Oncology
Low Grade Astrocytoma Presenting with Visual Loss
de Groot JF, Gilbert MR, Aldape K, Hess KR, Hanna TA, Ictech S, Groves MD, Conrad C, Colman H, Puduvalli VK, Levin V, Yung WK
Journal of Neuro-Oncology
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma
Suki D, Abouassi H, Patel AJ, Sawaya R, Weinberg JS, Groves MD
Journal of Neurosurgery
Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa
Huston JM, King H, Maresh H, Liska D, Port JL, Altorki NK, Lee PC.
Journal of Thoracic and Cardiovascular Surgery
Hernia of Morgagni: case report
Weiss, Brendan M and Shumway, Nathan M and Howard, Robin S and Ketchum, Lloyd K and Reid, Thomas J
Journal of Thrombosis and Thrombolysis
Optical density values correlate with the clinical probability of heparin induced thrombocytopenia
Arlen PM, Bianco F, Dahut WL, D'Amico A, Figg WD, Freedland SJ, Gulley JL, Kantoff PW, Kattan MW, Lee A, Regan MM, Sartor O, Prostate Specific Antigen Working Group
Journal of Urology
Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time

Roger M. Lyons
David J Kuter, James B Bussel, Vinod Pullarkat, Terry B Gernsheimer, Francis M Senecal, Louis M Aledort, James N George, Craig M Kessler, Miguel A Sanz, Howard A Liebman, Frank T Slovick, J Th M de Wolf, Emmanuelle Bourgeois, Troy H Guthrie Jr, Adrian Newland, Jeff rey S Wasser, Solomon I Hamburg, Carlos Grande, François Lefrère, Alan Eli Lichtin, Michael D Tarantino, Howard R Terebelo, Jean-François Viallard, Francis J Cuevas, Ronald S Go, David H Henry, Robert L Redner, Lawrence Rice, Martin R Schipperus, D Matthew Guo, Janet L Nichol

Lancet
Efficacy of Romiplostim in Patients with Chronic Immune Thrombocytopenic Purpura: a Double-blind Randomised Controlled Trial

Download full publication here.

Jones, Stephen E. M.D. 
Luc Yves Dirix, Jorge Ignacio, Shona Nag, Poonamally Bapsy, Henry Gomez, Digumarti Raghunadharao, Robert Paridaens, Silvia Falcon, Marina Carpentieri, Antonello Abbattista, Jean-Pierre Lobelle

Journal of Clinical Oncology

Treatment of Advanced Hormone-Sensitive Breast Cancer in Postmenopausal Women With Exemestane Alone or in Combination with Celecoxib

Esler, William Vance, M.D. 
Lim, S.H., Zhang, Y., Zhang, J., Periman, P.O., Burris, C., Townsend, M.

Leukemia and Lymphoma
B-cell depletion for 2 years after autologous stem cell transplant for NHL induces prolonged hypogammaglobulinemia beyond the rituximab maintenance period.
Puduvalli VK, Pierre G, Groves MD, Hess K, Gilbert MR, Mahankali S, Jackson E, Levin V, Conrad CA, Hsu S, Colman H, DeGroot J, Ritterhouse M, Ictech S, Yung WK
Neuro-Oncology
Phase II Trial of Irinotecan and Thalidomide in Adults with Recurrent Glioblastoma Multiforme
Harstad L, Hess KR, Groves MD
Neuro-Oncology
Prognostic Factors and Outcomes in Patients with Leptomeningeal Melanomatosis
Taddei PJ, Fontenot JD, Zheng Y, Mirkovic D, Lee AK, Titt U, Newhauser WD
Physics in Medicine and Biology
Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer
Shumway, Nathan M and Wilson, Ramey L and Howard, Robin S and Parker, Joseph M and Eliasson, Arn H
Respiratory Medicine
Presence and treatment of air hunger in severely ill patients
Brown KM, Lango M, Ridge JA
Seminars in Oncology
The Role of Neck Dissection in the Combined Modality Therapy Setting
Sturgeon JD; Folsom AR; Longstreth WT; Shahar E; Rosamond WO; Cushman M.
Stroke
Hemostatic and Inflammatory Risk Factors for Intracerebral Hemorrhage in a Pooled Study.
Brown KM, Siripurapu V, Davidson M, Cohen SJ, Konski A, Watson JC, Li T, Ciocca V, Cooper H, Hoffman JP
The American Journal of Surgery
Chemoradiation Followed by Chemotherapy Before Resection for Borderline Pancreatic Adenocarcinoma
Saunders N, Kueck A, Haefner H
The Female Patient
Classification of Vulvar Intraepithelial Neoplasia
Spiess PE, Busby JE, Jordan JJ, Steinberg JR, Bassett RL, Davuluri R, Burt K, Troncoso P, Lee AK, Taylor SH, Pisters LL
Urologic Oncology
Can digital rectal examination or transrectal ultrasonography biopsy findings predict the side of nodal metastasis in prostate cancer?
Chawla, Jane S.
UT Southwestern
Paroxysmal Nocturnal Hemoglobinuria
Chawla, Jane S.
Washington University in St. Louis
The Natural Killer Cell Neoplasms: Can We Overcome Treatment Resistance?

Barker Jr., Jerry L., M.D. 
O’Daniel JC, Rosenthal DI, Garden AS, Ahamad A, Ang KK, Asper JA, Blanco AI, de Crevoisier R, Holsinger FC, Patel CB, Schwartz DL, Wang H, Dong L.

American Journal of Clinical Oncology
The effect of dental artifacts, contrast media, and experience on interobserver contouring variations in head and neck anatomy.

Shivnani, Anand M.D. 
 Small W Jr., Stryker SJ, et al.

American Journal of Surgery
Preoperative chemoradiation in rectal cancer: results of multimodality management and analysis of prognostic factors.
Priebe A, Kueck A, Tan L, Opipari A, Liu JR
Annual Meeting of the Society of Gynecologic Oncologists
Exploiting the Glycolytic Phenotype in Ovarian Cancer Cells: Novel Target for Therapy

John Sandbach, MD
David Loesch, MD; F. Anthony Greco, MD; Joyce O'Shaughnessy, MD; Nicholas Robert, MD; Neil N. Senzer, MD; John D. Hainsworth, MD; Sasha Vukelja, MD; Frankie Holmes, MD; Scot Sedlacek, MD; Deborah Lindquist, MD; Jario Olivares, MD; Kristi A. Boehm, MS; Feng Zhan, PhD; Lina Asmar, PhD

ASC Journal of Clinical Oncology
A randomized, multicenter phase III trial comparing regimens of doxorubicin + cyclophosphamide followed by paclitaxel or doxorubicin + paclitaxel followed by weekly paclitaxel as adjuvant therapy for patients with high risk breast cancer

Hutson, Thomas E. DO, PharmD, FACP 

Baylor Health Care Center Proceedings
Targeted therapy for renal cell carcinoma: A new treatment paradigm
Spiess PE, Lee AK, Busby JE, Jordan JJ, Hernandez M, Burt K, Troncoso P, Merriman KW, Pisters LL
BJU International
Surgically managed lymph node-positive prostate cancer: does delaying hormonal therapy worsen the outcome?
Lee AK, D'Amico AV
BJU International
Using prostate-specific antigen doubling time in clinical practice

R. Lyons
T. Cosgriff, S. Modi, H. McIntyre, I. Fernando, J. Backstrom, C. L. Beach

Blood
Results of the Initial Treatment Phase of a Study of Three Alternative Dosing Schedules of Azacitidine (Vidaza) in Patients with Myelodysplastic Syndromes (MDS)

Download full publication here.

Roger Lyons
James N. George, Francois Lefrere, Alan E. Lichtin, Michael D. Tarantino, Howard R. Terebelo, Jean-Francois Viallard, Reggie Kelly, Matthew Guo, Janet Nichol

Blood
Evaluation of AMG 531 Safety in Splenectomized (S) and Nonsplenectomized (NS) Patients with Chronic Immune Thrombocytopenic Purpura (ITP) in Two Randomized Placebo-Controlled Phase 3 Studies

Download full publication here.

Roger Lyons
James N. George, Francis J. Cuevas, Ronald S. Go, David H. Henry, Robert L. Redner, Lawrence Rice, Martin R. Schipperus, Susan D. Mathias, Sue Gao, Matthew Guo, Janet L. Nichol

Blood
Health-Related Quality of Life (HRQoL) in Patients with Chronic Immune Thrombocytopenic Purpura (ITP): Results from Two Placebo-Controlled Phase 3 Studies of AMG 531

Download full publication here.

Roger Lyons
Hagop Kantarjian, Pierre Fenaux, Mikkael A. Sekeres, Pamela Becker, Adam Boruchov, David Bowen, Richard Larson, Petra Muus, Jamile Shammo, Michael Ehrman, Kuolung Hu, Janet Nichol

Blood
Phase 1/2 Study of AMG 531 in Thrombocytopenic Patients with Low Risk Myelodysplastic Syndrome (MDS): Update on Extended Treatment

Download full publication here.

Estil A. Vance III, M.D. 
Drew J. Winson, Jo-Anne H. Young, Vinod Pullarkat, Genovefa A. Papanicolaou, Ravi Vij, George J. Alangaden, Roy F., Chemaly, Finn Petersen, Nelson Chao, Jared Klein, Kellie Sprague, Stephen A. Villano, and Michael Boeckh.

Blood
Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem-cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study.

Hutson, Thomas E. DO, PharmD, FACP 
T Powles, CJ Sweeney, MD Galsky, N Hahn, and CN Sternberg.

British Journal of Urology International
Novel agents for urothelial cancer: review

Roger Lyons
Kantarjian H, Giles F, List A, Sekeres MA, Pierce S, Deuson R, Leveque J.

Cancer
The Incidence and Impact of Thrombocytopenia in Myelodysplastic Syndromes

Download full publication here.

Nguyen PL, D'Amico AV, Lee AK, Suh WW
Cancer
Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature

Hutson, Thomas E. DO, PharmD, FACP 
K Chi, T Powles, CJ Sweeney, N Hahn, MD Galsky, WR Berry and D Kadman

Cancer
Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.

Roger Lyons, MD
Hagop Kantarjian, MD, Francis Giles, MD, Alan List, MD, Mikkael A. Sekeres, MD, Sherry Pierce, BSN, Robert Deuson, PhD, Joseph Leveque, MD

Cancer
The Incidence and Impact of Thrombocytopenia in Myelodysplastic Syndromes

Download full publication here.

Hutson, Thomas E. DO, PharmD, FACP 
George, T Mekhail, L Wood, J Finke, P Elson, R Dreicer, and RM Bukowski.

Cancer Chemotherapy and Pharmacology
Phase I trial of PEG-Intron and rIL-2 in patients with metastatic renal cell carcinoma
Quiros RM, Brown KM, Hoffman JP
Cancer Investigation
Neoadjuvant Therapy in Pancreatic Cancer

Blum, Joanne L. M.D., Ph.D. 
Freibel TM, Domcheck SM, Neuhausen SL, Wagner T, Evans DG, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson G, Lynch HT, Tung N, Weitzel J, Rubinstein WS, Ganz PA, Couch F, Rebbeck TR.

Clinical Breast Cancer
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 Mutation Carriers.

Blum, Joanne L. M.D., Ph.D. 
Savin M, Edelman G, Pippen J, Robert N, Geister B, Kirby R, Clawson A, O’Shaughessy J.

Clinical Breast Cancer
Phase 2 study of weekly nab-Paclitaxel for the treatment of patients with metastatic breast cancer heavily pretreated with taxanes.

Pippen, John E., JR. MD, F.A.C.P. 
Blum J, Savin M, Edelamn G, et al.

Clinical Breast Cancer
Phase II study of weekly albumin bound paclitaxel for patients with breast cancer heavily pretreated with taxanes.

Hutson, Thomas E. DO, PharmD, FACP

Current Oncology Report
A novel multitargeted tyrosine kinase inhibitor.

Hutson, Thomas E. DO, PharmD, FACP

Expert Opinion on Biological Therapy
Recent advances in the therapy of renal cancer.

Hutson, Thomas E. DO, PharmD, FACP 

Expert Review of Anticavity Therapy
Safety and tolerability of sorafenib in clear-cell renal cell carcinoma – a phase III overview.
Kueck A, Opipari A, Tan L, Choi M, Huang J, Wahl H, Liu JR
Gynecologic Oncology
Resveratrol Inhibits Glucose Metabolism in Human Ovarian Cancer Cells
International Journal of Gynecology and Obstetrics
Sentinel Lymph Node Mapping in Gynecologic Malignancies
de Crevoisier R, Melancon AD, Kuban DA, Lee AK, Cheung RM, Tucker SL, Kudchadker RJ, Newhauser WD, Zhang L, Mohan R, Dong L
International Journal of Radiation Oncology
Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer
Cheung MR, Tucker SL, Dong L, de Crevoisier R, Lee AK, Frank S, Kudchadker RJ, Thames H, Mohan R, Kuban D
International Journal of Radiation Oncology
Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer
Zhang X, Dong L, Lee AK, Cox JD, Kuban DA, Zhu RX, Wang X, Li Y, Newhauser WD, Gillin M, Mohan R
International Journal of Radiation Oncology 
Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment

R. M. Lyons
T. Cosgriff, S. Modi, H. McIntyre, C. L. Beach, J. T. Backstrom

Journal of Clinical Oncology
Tolerability and Hematologic Improvement Assessed Using Three Alternative Dosing Schedules of Azacitidine in Patients with Myelodysplastic Syndromes

Download full publication here.

R.M. Lyons
T. Cosgriff, S. Modi, H. McIntyre, C. L. Beach, J. T. Backstrom

Journal of Clinical Oncology
Baseline Predictors of Response to Treatment with Darbepoeitin-alpha (DA) in Anemic Patients with Low-risk Myelodysplastic Syndrome (MDS)

Download full publication here.

R. M. Lyons
H. M. Kantarjian, F. J. Giles, P. Fenaux, P. S. Becker, A. M. Boruchov, D. T. Bowen, E. Hellström-Lindberg, R. A. Larson, P. Muus

Journal of Clinical Oncology
Evaluating Safety and Efficacy of AMG 531 for the Treatment of Thrombocytopenic Patients with Myelodysplastic Syndrome (MDS): Preliminary Results of a Phase 1/2 Study

Download full publication here.

Blum, Joanne L. M.D., Ph. D. 
Kauff ND, Domcheck SM, Freibel TM, Robson ME, Lee J, Garber JE, Isaacs C, Evans DG, Lynch HT, Eeles RA, Neuhasusen SL, Daly MB, Matloff E, Norton L, Offit K, Rebbeck TR.

Journal of Clinical Oncology
Recall injury from vinblastine: a case report.

Hoverman, J. Russell M.D. 
et. al.

Journal of Clinical Oncology
Assessment of medication safety in the outpatient setting.

Pippen, John E., JR. MD, F.A.C.P. 
Jones SE, Cantrell J, Vukelja S, et al.

Journal of Clinical Oncology
Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: a report of a tamoxifen exemestane adjuvant multicenter trial substudy.

Patt, Debra M.D. 
Duan, Zhigang. Fang, Shenying. Hortobagyi, Gabriel N. and Giordano, Sharon H.

Journal of Clinical Oncology
Acute Myeloid Leukemia after Adjuvant Breast Cancer Therapy in Older Women: Understanding Risk.

Mennel, Robert G. M.D., FACP 
Harris L, Fritsche H, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF. Bast RC Jr.

Journal of Clinical Oncology
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

Roger Lyons
Hagop M. Kantarjian, Francis Giles, Alan F. List, Roger Lyons, Sherry Price, Robert Deuson, Joseph Leveque

Journal of Community and Supportive Oncology
The Incidence and Impact of Thrombocytopenia in Myelodysplastic Syndrome

Download full publication here.

R. M. Lyons
H.M. Kantarjian, F.J. Giles, P. Fenaux, P.S. Becker, A.M. Boruchov, D. Bowen, E. Hellstrom-Lindberg, R.A. Larson, R.M. Lyons, P. Muus

Journal of Community and Supportive Oncology
The Efficacy and Safety of Darbopoetin Alfa For Treating Anemia in Low-Risk Myelodysplastic Syndrome Patients: Results After 53-55 Weeks

Download full publication here.

Roger Lyons
David Kuter, James B. Bussel, James George, Louis Aledort, Alan Lichtin, Roger Lyons, Jorge Nieva, Jeffrey Wasser, Emanuelle Bourgeois, Mies Kappers-Klunne, Francois Lefrere, Martin Schipperus, Reggie Kelly, Jenny Christal, Matthew Guo, and Janet Nichol

Journal of Community and Supportive Oncology
Long-term Dosing of AMG 531 in Thrombocytopenic Patients with Immune Thrombocytopenic Purpura: 48-week Update

Download full publication here.

Groves MD, Puduvalli VK, Chang SM, Conrad CA, Gilbert MR, Tremont-Lukats IW, Liu TJ, Peterson P, Schiff D, Cloughesy TF, Wen PY, Greenberg H, Abrey LE, Deangelis LM, Hess KR, Lamborn KR, Prados MD, Yung WK.
Journal of Neuro-Oncology
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme

Pippen, John E., JR. MD, F.A.C.P. 

Journal of Oncology Practice
Maintenance of certification: my perspective.
Khwaja FW, Reed MS, Olson JJ, Schmotzer BJ, Gillespie GY, Guha A, Groves MD, Kesari S, Pohl J, Van Meir EG
Journal of Proteome Research
Proteomic Identification of Biomarkers in the Cerebrospinal Fluid (CSF) of Astrocytoma

Shivnani, Anand M.D. 

Journal of the American Medical Association
Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer (Letter ot Editor)
Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA
Journal of Urology
An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer
Zullo JR, Kudchadker R, Wu R, Lee A, Prado K
Medical Dosimetry
Implication of CT table sag on geometrical accuracy during virtual simulation
Sturgeon JD; Folsom AR
Neuroepidemiology
Trends in the hospitalization rate, hospital case fatality, and mortality rate of stroke by subtype in Minneapolis-St Paul.

Hutson, Thomas E. DO, PharmD, FACP 
RJ Motzer, P Tomczak, MD Michaelson, RM Bukowski, O Rixie, S Oudard, S Negrier, C Szczylik, ST Kim, I Chen, CM Baum and RA Figlin

New England Journal of Medicine
Phase III randomized trial of sunitinib malate versus interferon-alfa as first-line systemic therapy for patients with metastatic renal cell carcinoma.

Shivnani, Anand M.D. 

New England Journal of Medicine
Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer.

Hutson, Thomas E. DO, PharmD, FACP 
B. Escudier, T. Eisen, W.M. Stadler, C. Szczylik, S. Oudard, M. Siebels, S. Negrier, C. Chevreau, E. Solska, A. Desai, F. Rolland, T. Demkow, M. Gore, S Freeman, B Schwartz, M. Shan, R. Simantov, R.M. Bukowski for the Sorafenib TARGETs Clinical Trial Group.

New England Journal of Medicine
Treatment Approaches in Renal cancer Global Evaluation Trial (TARGETs)

Hutson, Thomas E. DO, PharmD, FACP 
BJ Roth

Oncologist
Management of recurrent testicular germ cell tumors.

Hutson, Thomas E. DO, PharmD, FACP 
RA Figlin

Oncology
The evolving role of novel targeted agents in renal cell carcinoma.

Goldman, Stan M.D. 
Rakheja D, Wilson K, Lenarsky C, Weinthal J, Schultz R.

Pediatric and Developmental Pathology
Translocation associated primitive round cell sarcoma: report of a case and review of the literature.
Newhauser W, Fontenot J, Koch N, Dong L, Lee A, Zheng Y, Waters L, Mohan R
Physics in Medicine and Biology
Monte Carlo simulations of the dosimetric impact of radiopaque fiducial markers for proton radiotherapy of the prostate
Melancon AD, O'Daniel JC, Zhang L, Kudchadker RJ, Kuban DA, Lee AK, Cheung RM, de Crevoisier R, Tucker SL, Newhauser WD, Mohan R, Dong L
Radiotherapy & Oncology
Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer?
Sturgeon JD; Folsom AR; Longstreth WT; Shahar E; Rosamond WO; Cushman M.
Stroke
Risk Factors for lntracerebral Hemorrhage in a Pooled Prospective Study.

R. Lyons
H.M. Kantarjian1, F. Giles, A.F. List, M. Sekeres4, S. Pierce1, R. Deuson, J. Leveque

Supportive Care Cancer
Thrombocytopenia in MDS: Incidence and Impact

Download full publication here.

R. M. Lyons
H.M. Kantarjian, F.J. Giles, P. Fenaux, P.S. Becker, A.M. Boruchov, D. Bowen, E. Hellstrom-Lindberg, R.A. Larson, R.M. Lyons, P. Muus

Supportive Care Cancer
Evaluating Safety and Efficacy of AMG 531 for the Treatment of Thrombocytopenic Patients with Myelodysplastic Syndrome (MDS): Preliminary Results of a Phase 1/2 Study

Download full publication here.

Lee AK
The American Journal of Hematology/Oncology
Commentary on "Cancer Specific Mortality After Radiation Therapy with Short-Course Hormonal Therapy or Radical Prostatectomy in Men with Localized, Intermediate-Risk to High-Risk Prostate Cancer"
Hurtuk M, Devata S, Brown KM, Oshima K, Aranha GV, Pickleman J, Shoup M
The American Journal of Surgery
Should All Patients with Duodenal Adenocarcinoma Be Considered for Aggressive Surgical Resection?
Brown KM, Flaherty JF, Ciocca V, Ehya H, Ruth K, Scott WS, Goldberg M
The American Society of Clinical Oncology
Touch Prep Cytology as a Tool for Determining Pulmonary Parenchymal Resection Margin Status
Brown KM, Heimann D, Cordera F, Watson JC, Hoffman JP
The Annals of Surgical Oncology
Is Pancreatic Resection Justifiable in the Presence of Locally Advanced (R2) or Metastatic (M1) Disease?

Hutson, Thomas E. DO, PharmD, FACP 
RA Figlin

The Cancer Journal
Renal Cell Carcinoma: Recent Advances.

Pippen, John E., JR. MD, F.A.C.P. 
Gong Y, Yan K, et al.

The Lancet
Determination of oestrogen-receptor status and erb b2 status of breast carcinoma: a gene expression profiling study.

Hutson, Thomas E. DO, PharmD, FACP 
E Segota, T Mekhail, T Olencki, R Dreicer, B Wacker, B Osterwalder, P Elson, M Zhou, and RM Bukowski

Urology Oncology
Phase II trial of capecitabine and rHU-interferon-alpha-2a in patients with metastatic renal cell carcinoma, limited efficacy and moderate toxicity.

McCollum, David M.D. 
Bingyan Wu, Jeffrey W. Clark, Matthew H. Kulke, Peter C. Enzinger, David P. Ryan, Craig Earle, Ann Michelini, Charles S. Fuchs, MD, MPH.

American Journal of Clinical Oncology
The Combination of Capecitabine and Thalidomide in Previously Treated, Refractory Metastatic Colorectal Cancer.

Hutson, Thomas E. DO, PharmD, FACP 
TK Choueiri, T Mekhail, R Ganapathi, GE Kelly and RM Bukowski

Annals of Oncology
Phase I trial of phenoxodiol delivered by continuous intravenous infusion.
DeZee, Kent J and Shimeall, William T and Douglas, Kevin M and Shumway, Nathan M and O’Malley, Patrick G
Archives of Internal Medicine
Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis

John Sandbach, M.D.
John Cox, M.D.; Marcus Neubauer, M.D.; Andrew D. McCollum, M.D.; Thomas Cartwright, M.D.; Michael A. Monticelli, M.D.; Kristi A. Boehm, M.S.; Des Ilegbodu, DrPh; Lina Asmar, Ph.D.

ASCO Gastrointestinal Cancers Symposium
A Phase II study of gemcitabine plus zoledronic acid in Stage IV cancer of the pancreas.

Cooper, Barry, M.D. 
Gregory, T.F.

Baylor University Medical Center Proceedings
Case report of an acquired factor XIII inhibitor: diagnosis and management.

Cooper, Barry, M.D. 
Roberts, W.C.

Baylor University Medical Center Proceedings
MD: a conversation with the editor.

Roger M. Lyons
Louis M. Aledort, Gary Okano, Joseph Leveque

Blood
The Clinical and Direct Medical Cost Burden of Splenectomy Among Managed Care Patients with Chronic Immune Thrombocytopenic Purpura (ITP)

Download full publication here.

Roger M. Lyons
Louis M. Aledort, Gary Okano, Joseph Leveque

Blood
Retrospective Matched Cohort Study of Immune Thrombocytopenic Purpura (ITP): Complications Related to Corticosteroid (CS) Use

Download full publication here.

Roger M. Lyons
David Kuter, James Bussel, James George, Louis Aledort, Alan Lichtin, Jorge Nieva, Jeffrey Wasser, Emanuelle Bourgeois, Mies Kappers-Klunne, Francois Lefrere, Martin Schipperus, Reggie Kelly, Jenny Christal, Matthew Guo, Janet Nichol

Blood
Long-term Dosing of AMG 531 in Thrombocytopenic Patients with Immune Thrombocytopenia Purpura: 48-week Update

Download full publication here.

Roger M. Lyons
Hagop M. Kantarjian, Francis Giles, Alan F. List, Sherry Price, Robert Deuson, Joseph Leveque

Blood
The Incidence and Impact of Thrombocytopenia in Myelodysplastic Syndromes (MDS)

Download full publication here.

Roger M. Lyons
Thomas Cosgriff, Sanjiv Modi, Heidi McIntyre, C.L. Beach, Jay T. Backstrom

Blood
Hematologic Improvement, Transfusion Independence, and Safety Assessed Using Three Alternative Dosing Schedules of Azacitidine in Patients with Myelodysplastic Syndromes

Download full publication here.

Roger M. Lyons
Janice Gabrilove, Ronald Paquette, Chaudhry Mushtaq, Mikkael A. Sekeres, Hung Lam, Lyndah Dreiling

Blood
The Efficacy and Safety of Darbopoetin Alfa For Treating Anemia in Low-Risk Myelodysplastic Syndrome Patients: Results After 53-55 Weeks

Download full publication here.

John Sandbach
Frankie Ann Holmes, David Loesch, Sasha Vukelja, Joanne L Blum, Kristi J McIntyre, John E Pippen1, WJ Hyman, Don A Richards, Kristi Boehm, Lina Asmar, Joyce O’Shaughnessy.

Breast Cancer Research and Treatment
Are granulocyte colony-stimulating growth factors (CSF’s) needed to prevent febrile neutropenia (FN) for course #1 of adjuvant chemotherapy with “standard” doxorubicin-cyclophosphamide (ASC) Results from two consecutive US Oncology community adjuvant trials.

Balasubramanian, Lakshmi M.D. 
Bennett CL, Evens AM, Andritsos LA, Mai M, Fisher MJ, Kuzel TM, Angelotta C, McKoy JM, Vose JM, Bierman PJ, Kuter DJ, Trifilio SM, Devine SM, Tallman MS.

British Journal of Haematology
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.

Hellerstedt, Beth M.D. 
Mackler NJ, Dunn RL, Cooney KA, Fardig J, Olson K, Pienta KJ, Smith DC.

Cancer
Dose Escalation of Oral Vinorelbine in Combination with Estramustine in Hormone-Refractory Adenocarcinoma of the Prostate

Hutson, Thomas E. DO, PharmD, FACP 
RJ Halbert, RA Figlin, MB Atkins,  M Bernal, TE Hutson, RG Uzzo, RM Bukowki, KD Khan, RJ Motzer, CG Wood, and  R Dubois

Cancer
Treatment of Patients with Metastatic Renal Cell Carcinoma: A RAND appropriateness panel
Giordano SH, Lee A, Kuo YF, Freeman J, Goodwin JS
Cancer
Late gastrointestinal toxicity after radiation for prostate cancer
Spiess PE, Lee AK, Leibovici D, Wang X, Do KA, Pisters LL
Cancer
Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy
Strom SS, Kamat AM, Gruschkus SK, Gu Y, Wen S, Cheung MR, Pisters LL, Lee AK, Rosser CJ, Kuban DA
Cancer
Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer
Rivera E, Meyers C, Groves M, Valero V, Francis D, Arun B, Broglio K, Yin G, Hortobagyi GN, Buchholz T.
Cancer
Phase I Study of Capecitabine in Combination with Temozolomide in the Treatment of Patients with Brain Metastases From Breast Carcinoma
Rivera E, Meyers C, Groves M, Valero V, Francis D, Arun B, Broglio K, Yin G, Hortobagyi GN, Buchholz T
Cancer
Phase I Study of Capecitabine in Combination with Temozolomide in the Treatment of Patients with Brain Metastases From Breast Carcinoma

Roger M. Lyons, MD
Steven R. Deitcher, MD, Craig M. Kessler, MD, Geno Merli, MD, James R. Rigas, MD, Roger M. Lyons, MD, Jawed Fareed, PhD

Clinical and Applied Thrombosis/Hemostasis
Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period

Download full publication here.

Blum, Joanne L. M.D., Ph.D. 
O’Shaughnessy, JA.

Clinical Breast Cancer
Capecitabine/taxane combination therapy: evolving clinical utility in breast cancer.

Pippen, John E., JR. MD, F.A.C.P. 
Dodwell, D.

Clinical Breast Cancer
Time to response: comparison of fulvestrant and oral endocrine agents.
Wen PY, Yung WK, Lamborn KR, Dahia PL, Wang Y, Peng B, Abrey LE, Raizer J, Cloughesy TF, Fink K, Gilbert M, Chang S, Junck L, Schiff D, Lieberman F, Fine HA, Mehta M, Robins HI, DeAngelis LM, Groves MD, Puduvalli VK, Levin V, Conrad C, Maher EA, Aldape K, Hayes M, Letvak L, Egorin MJ, Capdeville R, Kaplan R, Murgo AJ, Stiles C, Prados MD
Clinical Cancer Research
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study

Hutson, Thomas E. DO, PharmD, FACP 
RM Bukowski

Clinical Genitourinary Cancer
A phase II study of GW786034 using a randomized discontinuation design in patients with locally recurrent or metastatic clear-cell renal cell carcinoma.

Hutson, Thomas E. DO, PharmD, FACP 
W Berry

Clinical Genitourinary Cancer
Systemic Chemotherapy for Urothelial Cancer.

Balasubramanian, Lakshmi M.D. 
Evens, AM.

Current Opinions in Oncology
Targeting angiogenesis for the treatment of sarcoma.

Barker Jr., Jerry L., M.D. 
Rosenthal DI, Asper JA, Garden AS, Chao KSC, Morrison WH, Weber RS, Ang KK.

Head Neck
Importance of patient examination to clinical quality assurance in head and neck radiation.
Lee AK, Frank SJ
Hematology/Oncology Clinics of North America
Update on radiation therapy in prostate cancer
Brown KM, Shoup M, Abodeely A, Hodul P, Brems JJ, Aranha GV
HPB
Central Pancreatectomy for Benign Pancreatic Lesions
Kueck A, Gossner G, Burke WM, Reynolds RK
International Journal of Gynecology and Obstetrics
Laparoscopic Technology in Endometrial Cancer
Son MJ, Song HS, Kim MH, Kim JT, Kang CM, Jeon JW, Park SY, Kim YJ, Groves MD, Park K, Kim JH, Nam DH
International Journal of Oncology
Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastoma
Zhang Y, Zhang L, Zhu XR, Lee AK, Chambers M, Dong L
International Journal of Radiation Oncology
Reducing metal artifacts in cone-beam CT images by preprocessing projection data
O'Daniel JC, Dong L, Zhang L, de Crevoisier R, Wang H, Lee AK, Cheung R, Tucker SL, Kudchadker RJ, Bonnen MD, Cox JD, Mohan R, Kuban DA
International Journal of Radiation Oncology 
Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy
Colman H, Berkey BA, Maor MH, Groves MD, Schultz CJ, Vermeulen S, Nelson DF, Mehta MP, Yung WK
International Journal of Radiation Oncology, Biology, Physics
Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710
Oplatek A, Brown KM, Sen S, Halerz M, Supple K, Gamelli RL
Journal of Burn Care & Research
Long-term Follow-up of Patients Treated for Toxic Epidermal Necrolysis

Blum, Joanne L. M.D., Ph.D. 
Dees EC, Chacko A, Loane L, Ethirajan S, Hopkins J, McMahon R, Merten S,  Negron A, Neubauer M, Ilegbodu D, Boehm K, Asmar L, O’Shaughnessy JA.

Journal of Clinical Oncology
Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer.

Blum, Joanne L. M.D., Ph.D. 
Jones SE, Savin MA. Holmes FA, O’Shaughnessy JA, Vukelja S, McIntryre KJ, Pippen JE, Kirby R, Sandbach J, Hyman WJ, Khandelwal P, Negron AG, Richards DA, Anthony SP, Mennel RG, Boehm KA, Mayer WG, and Asmar L,.

Journal of Clinical Oncology
Results of a Phase III trial doxoroubicin/cyclophosphamide (AC) compared to docetaxel/cyclophosphamide (TC) as adjuvant therapy for operable breast cancer.

Hoverman, J. Russell M.D. 
Hansen K, Richardson D, Shuey K.M., Dugger P.C.

Journal of Clinical Oncology
The Development of an Outpatient Chemotherapy Medication Safety Program.

Hutson, Thomas E. DO, PharmD, FACP 
Galsky, and WR Berry

Journal of Clinical Oncology
Problems with randomized discontinuation design.

Roger M. Lyons
Hagop M. Kantarjian, Francis Giles, Alan F. List, Sherry Price, Robert Deuson, Joseph Leveque

Journal of Clinical Oncology
Darbopoetin Alfa for Treating Anemia in Low-Risk Myelodysplastic Syndrome Patients: Interim Results After 27/28 Weeks

Download full publication here.

Roger M. Lyons
J. Gabrilove, R. Paquette, C. Mushtaq, M. Sekeres, H. Lam, L. Dreiling

Journal of Clinical Oncology
Darbepoetin Alfa for Treating Anemia in Patients with Low-Risk Myelodysplastic Syndromes: Exploratory Analysis of Baseline Predictors of Response

Download full publication here.

Roger M. Lyons
S. Anthony, T. Cosgriff, S. Modi

Journal of Clinical Oncology
Transfusion Independence Assessed During Three Alternative Dosing Schedules of Azacitidine in Patients with Myelodysplastic Syndromes

Download full publication here.

John Sandbach
Stephen E Jones, Michael A. Savin, Frankie Ann Holmes, Joyce A. O’Shaughnessy, Joanne L. Blum, Svetislava Vukelja, Kristi J. McIntyre, John E. Pippen, James H. Bordelon, Robert Kirby, William J. Hyman, Pankaj Khandelwal, Angel G. Negron, Donald A. Richards, Stephen P. Anthony, Robert G. Mennel, Kristi A. Boehm, Walter G. Meyer, Lina Asmar.

Journal of Clinical Oncology
Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer. 
Cloughesy TF, Wen PY, Robins HI, Chang SM, Groves MD, Fink KL, Junck L, Schiff D, Abrey L, Gilbert MR, Lieberman F, Kuhn J, DeAngelis LM, Mehta M, Raizer JJ, Yung WK, Aldape K, Wright J, Lamborn KR, Prados MD
Journal of Clinical Oncology
Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study
Groves MD, Puduvalli VK, Conrad CA, Gilbert MR, Yung WK, Jaeckle K, Liu V, Hess KR, Aldape KD, Levin VA
Journal of Neuro-Oncology
Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: A relationship among efficacy, joint toxicity and anticonvulsant status

Roger M. Lyons, M.D.
James B. Bussel, M.D., David J. Kuter, M.D., D.Phil., James N. George, M.D., Robert McMillan, M.D., Louis M. Aledort, M.D., George T. Conklin, M.D., Alan E. Lichtin, M.D., Jorge Nieva, M.D., Jeffrey S. Wasser, M.D., Israel Wiznitzer, M.D., Reggie Kelly, B.S., Chien-Feng Chen, Ph.D., Janet L. Nichol, M.S.

New England Journal of Medicine
AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITP

Download full publication here.

Shivnani, Anand M.D. 
 Rimel BJ, Schink J, and Small W Jr..

Oncology
Cancer of the Cervix: Current Management and New Approaches.
Kang SG, Kim JS, Park K, Groves MD, Nam DH
Oncology Reports
Combination celecoxib and temozolomide in C6 rat glioma orthotopic model
King, H.
Oregon Health Sciences University
Hurricane Katrina and the Effects on Academic Medicine.
Brenner B, Burke W, Dunn B, Kueck A, Rhode J, Garling W
Our Bodies Ourselves: Menopause
Cancers

McCollum, David M.D. 

Proc (Bayl Univ Med Cent)
Stage III colon cancer at Baylor University Medical Center at Dallas and the Baylor Sammons Cancer Center: experience from 2000 to 2004.
Lee AK
Seminars in Radiation Oncology
Radiation therapy combined with hormone therapy for prostate cancer

Esler, William Vance, M.D. 
Rohrer JE, Saeed Q, Saeed S, Periman P, Beggs D, Hancock P, Lim S.H.

Support Care Center
Risk of mistaken DNR orders.

Hoverman, J. Russell M.D. 
Syrigos KN, Nutting CM, Roussos C, eds.

Tumors of the Chest - Biology, Diagnosis and Management
Financial Aspects of Lung Cancer.
Chawla, Jane S.
UT Southwestern
Acute Intermittent Porphyria

Patt, Debra M.D. 
Giordano, Sharon H.

Women's Health
Paclitaxel in Breast Cancer.
Kueck A, Tan L, Choi A, Opipari A, Liu JR
 
AACR Annual Clinical Meeting
Inhibition of Glycolysis: Novel Therapy for Ovarian Cancer
Burke W, Gassner G, Kueck A, Choi A, Liu JR
AACR Annual Clinical Meeting
Genistein Inhibits Glucose Uptake and Induces Autophagy in Ovarian Cancer Cells
Lee CT, Dong L, Ahamad AW, Choi H, Cheung R, Lee AK, Horne DF, Breaux AJ, Kuban DA
American Journal of Clinical Oncology
Comparison of treatment volumes and techniques in prostate cancer radiation therapy
Kharod SM, Herman MP, Mendenhall WM, Morris CG, Mendenhall NP.
American Journal of Clinical Oncology
Radiotherapy in the Management of Orbital Lymphoma: A Single Institution’s Experience Over 4 Decades
Schatz S. Kramer S.
American Urological Association
Renal Ectopia and Fusion Abnormalities
Courtney Sheinbein M.D., Arnold C. Paulino M.D., Bin S. Teh M.D., Wei Y. Mai M.D., T. John Van M.D., E. Brian Butler M.D.
Annual Meeting of the Radiological Society of North America
Postoperative Intensity Modulated Radiation Therapy (IMRT) for Head and Neck Cancer: Does the Scar Need to be Included in the Clinical Target Volume?
Gassner G, Kueck A, Choi A, Kuenker M, Liu J
Annual Meeting of the Society of Gynecologic Oncologists
Genistein Inhibits Activation of Akt and Glycolysis in Ovarian Cancer Cells
Kueck A, Tan L, Choi A, Opipari A, Liu JR
Annual Meeting ofthe Society of Gynecologic Oncologists
Targeting Glucose Metabolism in Ovarian Cancer
Quinn A, Brown KM, Curry J, Gordon KB, Sinacore J, Gamelli RL, Nickoloff BJ
Archives of Dermatology
Uncovering Histological Criteria with Prognostic Significance in Toxic Epidermal Necrolysis
Brown KM, Thompkins A, Yong S, Aranha GV, Shoup M
Archives of Surgery
Pancreaticoduodenectomy Is Curative in the Majority of Patients with Node-negative Ampullary Cancer
Courtney Sheinbein, M.D., Hsin Lu, M.D., John McGary, Ph.D., Charlotte Prado, C.M.D., Thomas Mathews, B.S.R.D. and Bin S. Teh, M.D.
Baylor College of Medicine 3rd Annual Cancer Center Symposium
Partial Breast Irradiation with 3-dimensional Conformal Radiation and Helical Tomotherapy--a Dosimetric Comparison
Leibovici D, Lee AK, Cheung RM, Spiess PE, Kuban DA, Rosser CJ, Shen Y, Yang Y, Chichakli R, Pisters LL
Cancer
Symptomatic local recurrence of prostate carcinoma after radiation therapy
Giglio P, Weinberg JS, Forman AD, Wolff R, Groves MD
Cancer
Neoplastic meningitis in patients with adenocarcinoma of the gastrointestinal tract
McDonald JM, See SJ, Tremont IW, Colman H, Gilbert MR, Groves M, Burger PC, Louis DN, Giannini C, Fuller G, Passe S, Blair H, Jenkins RB, Yang H, Ledoux A, Aaron J, Tipnis U, Zhang W, Hess K, Aldape K
Cancer
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors
Cheung R, Tucker SL, Lee AL, Dong L, Kamat A, Pisters L, Kuban DA 
International Journal of Radiation Oncology
Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy
Cheung R, Tucker SL, Lee AK, de Crevoisier R, Dong L, Kamat A, Pisters L, Kuban D
International Journal of Radiation Oncology
Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy
Wang H, Dong L, Lii MF, Lee AL, de Crevoisier R, Mohan R, Cox JD, Kuban DA, Cheung R
International Journal of Radiation Oncology
Implementation and validation of a three-dimensional deformable registration algorithm for targeted prostate cancer radiotherapy
Cheung R, Kamat AM, de Crevoisier R, Allen PK, Lee AK, Tucker SL, Pisters L, Babaian RJ, Kuban D
International Journal of Radiation Oncology
Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy
Lee AK, Levy LB, Cheung R, Kuban D
International Journal of Radiation Oncology
Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy
Patt, D, Goodwin J, Kuo, Y, Freeman J, Zhang D, Buccholz T, Hortobagyi G, Giordano S.
Journal of Clinical Oncology
Cardiac morbidity of adjuvant radiotherapy in patients with early stage breast cancer
Lee AK, D'Amico AV
Journal of Clinical Oncology
Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy
Cloughesy TF, Kuhn J, Robins HI, Abrey L, Wen P, Fink K, Lieberman F, Mehta M, Chang S, Yung A, DeAngelis L, Schiff D, Junck L, Groves M, Paquette S, Wright J, Lamborn K, Sebti SM, Prados M
Journal of Clinical Oncology
Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: A North American brain tumor consortium study
Levin VA, Giglio P, Puduvalli VK, Jochec J, Groves MD, Yung WK, Hess K
Journal of Neuro-Oncology
Combination chemotherapy with 13-cis-retinoic acid and celecoxib in the treatment of glioblastoma multiforme
Dwyer RM. Schatz SM. Bergert ER. Myers RM. Harvey ME. Classic KL. Blanco MC. Frisk CS. Marler RJ. Davis BJ. O'Connor MK. Russell SJ. Morris JC.
Molecular Therapy: the Journal of the American Society of Gene Therapy
A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancer.
Davis BJ. Wilson TM. Mynderse LA. Schatz SM. Hillman DW.
Radiotherapy and Oncology
Analysis of pretreatment factors predictive of urinary morbidity following permanent prostate brachytherapy (PPB) including cystoscopic findings and uroflowmetry.
Patt D, Shopland D, Anderson C, Burns D, Dunnington J, Gritz E.
Texas Medicine
Trends to protect workers from job related secondhand smoke in Texas
Brown KM, Domin C, Yong S, Arahna GV, Shoup M.
The American Journal of Surgery
Increased Preoperative Platelet Count is Associated with Reduced Survival Following Resection for Pancreatic Cancer
Kueck A, Burke WM, Reynolds RK
The Female Patient
Anesthetic Issues and Complications Related to Laparoscopic Surgery
Rosser CJ, Kamat AM, Wang X, Do KA, Sanchez-Ortiz RF, Kuban DA, Lee AK, Cheung R, Chichakli R, Pisters LL
Urology
Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer?
Chawla, Jane S.
Washington University in St. Louis
Pharmacogenetics and Chemotherapy
Kueck A
5th International Conference on Ovarian Cancer at M.D. Anderson
Inhibition of Glucose Metabolism as a Novel Therapeutic Target for Ovarian Cancer
Kueck A, Tan L, Choi A, Opipari A, Liu JR
Annual District Meeting of District V Junior Fellows, ACOG
Targeting Glucose Metabolism in Ovarian Cancer
Kueck A, Tan L, Choi M, Wahl H, Fogoros S, Liu JR
Annual Meeting of Society of Gynecologic Oncologists
Resveratrol Induced Autophagocytosis is Associated with Expression of Beclin-1 in Ovarian Cancer
Shumway, Nathan M and Weiss, Brendan M and Ketchum, Lloyd H and Reid, Thomas J
Blood
Hematology Consultation along with the 4 T’s Clinical Scoring System Improves the Evaluation and Management of Heparin Induced Thrombocytopenia.

John Sandbach, M.D.
David Loesch, M.D.; F. Anthony Greco, M.D., Joyce O’Shaughnessy, M.D.; Nicholas Robert, M.D.; Neil N. Senzer, M.D.; Howard A. Burris, M.D.; John D. Hainsworth, M.D.; Sasha Vukelja, M.D.; Frankie Holmes, M.D.; Scot Sedlacek, M.D.; Deborah Lindquist, M.D.; Kristi A. Boehm, M.D.; Feng Zhan, Ph.D.; Lina Asmar, Ph.D.

Breast Cancer Research and Treatment
A randomized, multicenter phase III trial comparing regimens of doxorubicin + cyclophosphamide followed by paclitaxel or doxorubicin + paclitaxel followed by weekly paclitaxel as adjuvant therapy for patients with high risk breast cancer.
Wilson, Ramey L and Eliasson, Arn H and Shumway, Nathan M and Howard, Robin S and Shorr, Andrew F and Parker, Joseph M
CHEST Journal
Treating Air Hunger at End-of-Life
Shumway, Nathan M and Eliasson, Arn H and Wilson, Ramey L and Howard, Robin S and Shorr, Andrew F and Parker, Joseph M
CHEST Journal
Prospective Observation of Air Hunger in Severely Ill Patients
Okcu MF, Selvan M, Wang LE, Stout L, Erana R, Airewele G, Adatto P, Hess K, Ali-Osman F, Groves M, Yung AW, Levin VA, Wei Q, Bondy M
Clinical Cancer Research
Glutathione S-transferase polymorphisms and survival in primary malignant glioma
Court LE, Dong L, Taylor N, Ballo M, Kitamura K, Lee AK, O'Daniel J, White RA, Cheung R, Kuban D
International Journal of Radiation Oncology
Evaluation of a contour-alignment technique for CT-guided prostate radiotherapy: an intra- and interobserver study
Zagars GK, Ballo MT, Lee AK, Strom SS
Journal of Clinical Oncology
Mortality after cure of testicular seminoma
Puduvalli VK, Yung WK, Hess KR, Kuhn JG, Groves MD, Levin VA, Zwiebel J, Chang SM, Cloughesy TF, Junck L, Wen P, Lieberman F, Conrad CA, Gilbert MR, Meyers CA, Liu V, Mehta MP, Nicholas MK, Prados M
Journal of Clinical Oncology
Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study
Rosser CJ, Kuban DA, Lee SJ, Levy LB, Pettaway C, Kamat AM, Chichakli R, Lee A, Cheung RM, Sanchez-Ortiz R, Pisters LL
Journal of the National Medical Association
Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer
Citrin D, Lee AK, Scott T, Sproull M, Ménard C, Tofilon PJ, Camphausen K
Molecular Cancer Therapeutics
In vivo tumor imaging in mice with near-infrared labeled endostatin
See SJ, Levin VA, Yung WK, Hess KR, Groves MD
Neuro-Oncology
3-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme
Solhjem MS. Davis BJ. Schatz SM. Wilson TM. Mynderse LA. Hillman DW.
The Cancer Journal
The effect of neoadjuvant cytoreductive hormonal therapy on prostate volume, prostatic edema, and urinary morbidity after permanent prostate brachytherapy.
Brown KM, Silver GM, Halerz M, Walaszek P, Sandroni A, Gamelli RL
The Journal of Burn Care & Rehabilitation
Toxic Epidermal Necrolysis: Does Immunoglobulin Make a Difference?
Kamat AM, Rosser CJ, Levy LB, Chichakli R, Lee AK, Cheung MR, Pisters LL
Urology
Rise in serum PSA of 1.5 ng/mL above 24-month nadir after external beam radiotherapy is predictive of biochemical failure
Lawson RS
American Radium Society
Comparison of Conventional and Intensity Modulated Radiation Therapy (IMRT) in Children Requiring Whole Lung Radiation 
Merill RM; Hilton SC; Wiggins CL; Sturgeon JD
BMC Cancer
Toward a better understanding of the comparatively high prostate cancer incidence rates in Utah.
Ballo MT, Lee AK
Current Opinion in Oncology
Current results of brachytherapy for soft tissue sarcoma
Schatz SM. Lieber MM.
Current Urology Reports
Update on Oncocytoma
Lawson RS
Department of Radiation Oncology Grand Rounds. Emory University School of Medicine
RadioOncologic principles in the Treatment of Skin Cancers
Lawson RS
Grady Hospital School of Radiotherapy, resident lecture series
Genitourinary Malignancies
Jaramillo, S, Calof, AL.
Journal of Undergraduates in the Biological Sciences, University of California Irvine. Vol. 32
Growth and differentiation factor 11, a negative regulator of neural proliferation in the olfactory epithelium
Wu, H.H., Ivkovic, S., Murray, R.C., Jaramillo, S., Lyons, K.M., Johnson, J.E., Calof, A.L.
Neuron
Autoregulation of neurogenesis by GDF11
Lawson RS
Resident Research Day, Emory University School of Medicine
Benefits and Pitfalls of IMRT in Whole Lung Irradiation in Children
Griffin M.
Grand Rounds Presentation at NAMC
Nipple Sparing Mastectomy
Rosser CJ, Reyes AO, Vakar-Lopez F, Levy LB, Kuban DA, Hoover DC, Lee AK, Pisters LL
International Journal of Radiation Oncology
Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma
Lee HK, D'Souza WD, Yamal JM, Pollack A, Lee AK, Palmer MB, Kuban DA
International Journal of Radiation Oncology
Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer
Selek U, Lee A, Levy L, Kuban DA
International Journal of Radiation Oncology
Utility of the percentage of positive prostate biopsies in predicting PSA outcome after radiotherapy for patients with clinically localized prostate cancer
Giglio P, Tremont-Lukats IW, Groves MD
Journal of Neuro-Oncology
Response of neoplastic meningitis from solid tumors to oral capecitabine
Brown KM, Brems JJ, Moazzam FN, Hartman GG, Gamelli RL, Ding JW
Journal of the American Chemical Society
The Nitric Oxide Donor Molsidomine Improves Survival and Reduces Hepatocytes Apoptosis in Cholestasis and Endotoxemia
Rosser CJ, Levy LB, Kuban DA, Chichakli R, Pollack A, Lee A, Pisters LL
Journal of Urology
Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostate
Cox JD, Schechter NR, Lee AK, Forster K, Stevens CW, Ang KK, Komaki R, Liao Z, Milas L
Rays
Uncertainties in physical and biological targeting with radiation therapy
Lee AK, Doytchinova T, Chen MH, Renshaw AA, Weinstein M, Richie JP, D'Amico AV
Urologic Oncology
Can the core length involved with prostate cancer identify clinically insignificant disease in low risk patients diagnosed on the basis of a single positive core?
Sturgeon JD; Folsom AR; Bray MS; Boerwinkle E; Ballantyne CM
Stroke
Apolipoprotein E Genotype and Incident lschemic Stroke. The Athersosclerosis Risk in Communities Study.
Shumway NM, Kelly WF, Moquin ME, Eliasson AH.
American Thoracic Society ATS
Treatment of air hunger at end of life
Brown KM, Borge MA, Labropolous N, Baker, WH
Annals of Vascular Surgery
Pelvic Lymphocele Following Motor Vehicle Collision
Lawson RS
Resident Research Day, Emory University School of Medicine
Stereotactic Radiosurgery vs. Intensity Modulated Radiosurgery: Cheers and Challenges
Lawson RS
Department of Radiation Oncology Grand Rounds, Emory University School of Medicine
Review of Cumnt Treatment for Anal Cancer
Groves MD, Puduvalli VK, Hess KR, Jaeckle KA, Peterson P, Yung WK, Levin VA
Journal of Clinical Oncology
Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme
Schwarz RE, Fuller RA, Chu P. 
Journal of Clinical Oncology 
Gastric Carcinoid Metastatic to the Liver
Rosser CJ, Kuban DA, Levy LB, Chichakli R, Pollack A, Lee AK, Pisters LL
Journal of Urology
Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer
Tremont-Lukats IW, Fuller GN, Ribalta T, Giglio P, Groves MD
Neuro-Oncology
Paraneoplastic chorea: case study with autopsy confirmation
Oyelese Y, Kueck AS, Barter JF, Zalud I
Obstetrical & Gynecological Survey
Asymptomatic Postmenopausal Simple Ovarian Cyst
Linson PW, Lee AK, Doytchinova T, Chen MH, Weinstein MH, Richie JP, D'Amico AV
Urology
Percentage of core lengths involved with prostate cancer: does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer?
Gomez-Manzano C, Lemoine MG, Hu M, He J, Mitlianga P, Liu TJ, Yung AW, Fueyo J, Groves MD
Int J Oncol
Adenovirally-mediated transfer of E2F-1 potentiates chemosensitivity of human glioma cells to temozolomide and BCNU
Lee AK, Schultz D, Renshaw AA, Richie JP, D'Amico AV
International Journal of Radiation Oncology
Optimizing patient selection for prostate monotherapy
Sukin SW, Chhikara, Zhu Z, Ayala G, Kadmon D, Miles BJ, Thompson TC, Aguilar-Cordova E
Molecular Therapy
In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancer
Brown KM, Brems JJ, Holt DR, Moazzam F, Gamelli RL, Ding JW
Owen H. Wangensteen Surgical Forum
The Nitric Oxide Donor Molsidomine Attenuates Hepatocyte Apoptosis and Improves Survival in Cholestatic, Endotoxic Rat Model
Fuller RA, Wagman LD, Ellenhorn JDI, Crocitto LE, Wilson TG, Smith SS
86th Clinical Congress – American College of Surgeons, Surgical Oncology Forum I
Microfluidics Detection of Cancer with Telomerase RNA
Fuller RA, Kuhn JA, Fisher TL, Newsome TW, Smith BA, Jones RC
BUMC Proceedings
Laparoscopic Cholecystectomy for Acalculous Gallbladder Disease
Jabbour SH, Fuller, RA, Kuhn JA, Preskitt JT, Lieberman ZH, Derrick HC, Stephens JS, McCarty TM
North Texas Chapter - American College of Surgeons
Surgical Experience with Neuroendocrine Tumors of the Pancreas
Fuller RA, Wagman LD, Ellenhorn JDI, Crocitto LE, Wilson TG, Smith SS
Owen H. Wagensteen Surgical Forum
Microfluidics Detection of Cancer with Telomerase RNA
Brown, KM
Pediatric Surgery
Portal Hypertension
Crocitto LE, Fuller RA, Wagman LD, Kawachi  MH, Wilson TG, Smith SS
Society for Basic Urologic Research
Human Telomerase RNA (hTR) Inhibits Human DNA Methyltransferace, and Is Present in Expressed Prostatic Secretions (EPS) from Patients with Positive Biopsy for Prostate Cancer
Dimachkie MM, Ohanian S, Groves MD, Vriesendorp FJ
Urology
Peripheral nerve injury after brief lithotomy for transurethral collagen injection
Crociato LE, Fuller RA, Wagman LD, Kawachi  MH, Wilson TG, Smith SS
Western Section Annual Meeting - American Urological Association
Microfluidics Detection of Human Telomerase RNA in Expressed Prostatic Secretions
Groves MD, Maor MH, Meyers C, Kyritsis AP, Jaeckle KA, Yung WK, Sawaya RE, Hess K, Bruner JM, Peterson P, Levin VA
Int J Radiat Oncol Biol Phys
A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme
Groves MD, McCutcheon IE, Ginsberg LE, Kyritsis AP
Neurology
Radicular pain can be a symptom of elevated intracranial pressure
Fuller, RA, Roukounakis NE, Kuhn JA, McCarty TM, Jones RC
North Text Chapter - American College of Surgeons
Cholangiocarcinoma: Impact of Tumor Location
Fuller RA, Kuhn JA, Fisher TL, Newsome TW, Smith BA, Griffeth LK, Jones RC
Oral Poster Presentation - Southwestern Surgical Conference
Laparoscopic Cholecystectomy for Calculus Gallbladder Disease
Nguyen NT. Luketich JD. Schatz S. Tran Q. Ho HS. Schauer PR.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
Effect of open and laparoscopic surgery on cellular immunity in a swine model.
Mutchnik SE, Sukin SW, Boone, TB
Contemporary Urology
Case studies in voiding dysfunction
Susanto I, Wright SE, Lawson RS, Williams CE, Deneke SM
American Journal of Physiology
Metallothionein, glutathione, and cysteine transport in pulmonary artery endothelial cells and NIH/3T3 cells
Cho K, Hall W, Lee A, Gerbi B, Higgins P, Bohen M, Nussbaum E
Journal of Radiosurgery
Stereotactic radiosurgery for patients with single brain metastasis
Ingrams DR, Sukin SW, Ashton P, Valtonen HJ, Pankratov MM, Shapshay SM
Otolaryngology-Head and Neck Surgery
Does slow release of 5-fluorouracil and triamcinolone reduce subglottic stenosis?
Nguyen NT. Luketich JD. Shurin MR. Schatz S. Tran Q. Ravid J. Schauer PR.
Surgical Endoscopy
Coagulation modifications after laparoscopic and open cholecystectomy in a swine model.
Brown KM, Kristopaitis T, Yong S, Chejfec G, Pickleman J
The Journal of Gastrointestinal Surgery
Cystic Glucagonoma: A Rare Variant of an Uncommon Neuroendocrine Pancreas Tumor
Sielaff TD, Nyberg SL, Rollins MD, Hu MY, Amiot B, Lee A, Wu FJ, Hu WS, Cerra FB
Cell Biology and Toxicology
Characterization of the three-compartment gel-entrapment porcine hepatocyte bioartificial liver
Jeff Stephens, Joe Kuhn, John O'Brien, John Preskitt, Howard Derrick, Tammy Fisher, Rob Fuller, Zelig Lieberman
The American Journal of Surgery
Surgical Morbidity, Mortality, and Long-term Survival in Patients with Peripancreatic Cancer Following Pancreaticoduodenectomy
Erickson T, Brown KM, Widger H, Gillespie M
The Journal of Emergency Medicine
A case of Paraquat Poisoning and Subsequent Fatality Presenting to an Emergency Department
Richard M. Lemert, Rob A. Fuller, and Keith P. Johnston
The Journal of Physical Chemistry
Reverse Micelles in Supercritical Fluids: Amino Acid Solubilization in Ethane and Propane
Fischer DK, Groves MD, Thomas SJ, Johnson PC
Cancer Invest
Papillary carcinoma of the thyroid: additional evidence in support of a familial component
Loukas, D.F., Levick, S., Jacobs, C., Gordon, D.H., Meyskens, F.L., Uhm, K.
Pain
Naproxen Sodium in Treatment of Bone Pain Due to Metastatic Cancer
Loukas, D.F., Roland, J., Ellerby, R., Glassman, A.H., Lynch, D.P.
Internal Medicine for the Specialist
Multicenter Evaluation of Ketoconazole in the Treatment of Oral Thrush
Loukas, D.F., Costanzi, J.J., Gagliano, R.G., Delaney, F., Harris, N., Thurman, G.B., Sakai, H., Goldstein, A.L., Cohen, G.B., Thompson, P.D.
Cancer
The Effect of Thymosin on Patients with Disseminated Malignancies
Loukas, D.F., Costanzi, J.J., Gagliano, R.G., Griffith, C., Barranco, S.
Cancer
Intravenous Bleomycin Infusion as a Potential Synchronizing Agent in Humen Disseminated Malignancies
Loukas, D.F., Gagliano., R.G., Panettiere, F., Constanzi, J.J.
Paper presented: Southwest Section of AACR at University of Texas Medical Branch
Ifosfamide in the Treatment of Recurrent and Disseminated Lung Cancer
Loukas, D.F.
The American Journal of Medical Technology
Leukemic Reticuloendotheliosis:  A Medical Technologist’s Diagnosis
Loukas, D.F., Ritzmann, S.E., Sakai, H., Daniels, J.C., Levin, W.C.
Archives of Internal Medicine
Idiopathic (Asymptomatic-Benign) Monoclonal Gammopathies
Loukas, D.F., Costanzi, J.J., Griffiths, C., Gagliano, R.G., Barranco, S.
ASCO
Bleomyain Infusion for Disseminated Carcinoma
Loukas, D.F., Sakai, H., Costanzi, J.J., Gagliano, R.G., Ritzmann, S.E., Goldstein, A.L.
Cancer
Thymosin Induced Increase in E-Rosette Forming Capacity of Lymphocytes in Patients with Malignant Neoplasma
Loukas, D.F., Costanzi, J.J., Griffith, C., Gagliano, R.G., Barranco, S.
Clinical Research
Bleomycin Infusion for Disseminated Squamous Cell Carcinoma
Loukas, D.F., Costanzi, J.J., Gagliano, R.G., Sakai, H., Thurman, G., Harris, N., Goldstein, A.
Proceedings of the American Association for Cancer Research
The Use of Thymosin in Patients with Disseminated Neoplasia Toxicity and Immunological Correlation